<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7460449</article-id><article-id pub-id-type="doi">10.3390/antibiotics9080480</article-id><article-id pub-id-type="publisher-id">antibiotics-09-00480</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Plant-Based Phytochemicals as Possible Alternative to Antibiotics in Combating Bacterial Drug Resistance</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>AlSheikh</surname><given-names>Hana Mohammed Al</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00480">1</xref><xref ref-type="author-notes" rid="fn1-antibiotics-09-00480">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Sultan</surname><given-names>Insha</given-names></name><xref ref-type="aff" rid="af2-antibiotics-09-00480">2</xref><xref ref-type="author-notes" rid="fn1-antibiotics-09-00480">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Vijay</given-names></name><xref ref-type="aff" rid="af3-antibiotics-09-00480">3</xref><xref ref-type="author-notes" rid="fn1-antibiotics-09-00480">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2752-0519</contrib-id><name><surname>Rather</surname><given-names>Irfan A.</given-names></name><xref ref-type="aff" rid="af4-antibiotics-09-00480">4</xref></contrib><contrib contrib-type="author"><name><surname>Al-Sheikh</surname><given-names>Hashem</given-names></name><xref ref-type="aff" rid="af5-antibiotics-09-00480">5</xref></contrib><contrib contrib-type="author"><name><surname>Tasleem Jan</surname><given-names>Arif</given-names></name><xref ref-type="aff" rid="af6-antibiotics-09-00480">6</xref><xref rid="c1-antibiotics-09-00480" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Haq</surname><given-names>Qazi Mohd Rizwanul</given-names></name><xref ref-type="aff" rid="af2-antibiotics-09-00480">2</xref><xref rid="c1-antibiotics-09-00480" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-antibiotics-09-00480"><label>1</label>Department of Prosthetic Dental Sciences, College of Dentistry, Kind Saud University, Riyadh P.O. BOX 145111, Saudi Arabia; <email>halashaikh@ksu.edu.sa</email></aff><aff id="af2-antibiotics-09-00480"><label>2</label>Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India; <email>inshasultan12@gmail.com</email></aff><aff id="af3-antibiotics-09-00480"><label>3</label>Department of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 38541, Korea; <email>vijaykumarcbt@ynu.ac.kr</email></aff><aff id="af4-antibiotics-09-00480"><label>4</label>Department of Biological Sciences, Faculty of Science, King Abdul Aziz University, Jeddah P.O. BOX 80200, Saudi Arabia; <email>ammm@kau.edu.sa</email></aff><aff id="af5-antibiotics-09-00480"><label>5</label>Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia; <email>plxha@kfu.edu.sa</email></aff><aff id="af6-antibiotics-09-00480"><label>6</label>School of Biosciences and Biotechnology, Baba Ghulam Shah Badshah University, Rajouri 185234, India</aff><author-notes><corresp id="c1-antibiotics-09-00480"><label>*</label>Correspondence: <email>atasleem@bgsbu.ac.in</email> (A.T.J.); <email>haqqmr@gmail.com</email> (Q.M.R.H.)</corresp><fn id="fn1-antibiotics-09-00480"><label>&#x02020;</label><p>These authors contributed equally to the writing of the manuscript.</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2020</year></pub-date><volume>9</volume><issue>8</issue><elocation-id>480</elocation-id><history><date date-type="received"><day>25</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The unprecedented use of antibiotics that led to development of resistance affect human health worldwide. Prescription of antibiotics imprudently and irrationally in different diseases progressed with the acquisition and as such development of antibiotic resistant microbes that led to the resurgence of pathogenic strains harboring enhanced armors against existing therapeutics. Compromised the treatment regime of a broad range of antibiotics, rise in resistance has threatened human health and increased the treatment cost of diseases. Diverse on metabolic, genetic and physiological fronts, rapid progression of resistant microbes and the lack of a strategic management plan have led researchers to consider plant-derived substances (PDS) as alternative or in complementing antibiotics against the diseases. Considering the quantitative characteristics of plant constituents that attribute health beneficial effects, analytical procedures for their isolation, characterization and phytochemical testing for elucidating ethnopharmacological effects has being worked out for employment in the treatment of different diseases. With an immense potential to combat bacterial infections, PDSs such as polyphenols, alkaloids and tannins, present a great potential for use, either as antimicrobials or as antibiotic resistance modifiers. The present study focuses on the mechanisms by which PDSs help overcome the surge in resistance, approaches for screening different phytochemicals, methods employed in the identification of bioactive components and their testing and strategies that could be adopted for counteracting the lethal consequences of multidrug resistance.</p></abstract><kwd-group><kwd>antibiotics</kwd><kwd>bacteria</kwd><kwd>human health</kwd><kwd>plant-derived substances</kwd><kwd>resistance</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antibiotics-09-00480"><title>1. Introduction</title><p>Antibiotics are natural or synthetic organic molecules that are effective against microorganisms. With propensity to human use as defense armor, they provide protection against infections caused by bacteria and fungi. The emergence of resistance among microbes has limited the effectiveness of antibiotics, shifting the lifesaving paradigm built around them. This prominent trend is regarded as a matter of concern by agencies like the World Health Organization and has become a challenging situation for the medical fraternity worldwide [<xref rid="B1-antibiotics-09-00480" ref-type="bibr">1</xref>]. Despite incredible advancement in the scientific and modern medicine, the hopefulness of antibiotics is faded away by the appearance of different resistance mechanisms that presents a grave concern against the frontline antibiotics. Of them, antibiotic inactivation via, production of a range of enzymes, change in cell permeability, alteration of drug targets, intrinsic expression of efflux pumps and biofilm formation that acts as defense against drugs and contribute to sustained persistence of resistance bacteria [<xref rid="B2-antibiotics-09-00480" ref-type="bibr">2</xref>,<xref rid="B3-antibiotics-09-00480" ref-type="bibr">3</xref>,<xref rid="B4-antibiotics-09-00480" ref-type="bibr">4</xref>,<xref rid="B5-antibiotics-09-00480" ref-type="bibr">5</xref>,<xref rid="B6-antibiotics-09-00480" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-09-00480" ref-type="bibr">7</xref>]. In addition to mutations, mobile genetic elements (plasmids, insertion sequences, transposons and integrative conjugative elements) play a crucial role in the expansion of resistance among diverse groups of bacteria [<xref rid="B8-antibiotics-09-00480" ref-type="bibr">8</xref>]. Occurrence of resistance genes in bacteria favors their propagation and perpetuation in new territories. Contributing a unique niche for the growth of microorganisms, their establishment in the oral cavity especially dental surfaces serves as etiological agents of dental caries [<xref rid="B9-antibiotics-09-00480" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-09-00480" ref-type="bibr">10</xref>,<xref rid="B11-antibiotics-09-00480" ref-type="bibr">11</xref>]. There were a large number of reports that suggest irrational enhancement in prescribing antibiotics by medical professionals including dental surgeons that in turn contributes significantly amount to the growing burden of microbial resistance [<xref rid="B12-antibiotics-09-00480" ref-type="bibr">12</xref>,<xref rid="B13-antibiotics-09-00480" ref-type="bibr">13</xref>,<xref rid="B14-antibiotics-09-00480" ref-type="bibr">14</xref>]. Confronted by increasing amounts of antibiotics use, appearance of opportunistic organisms intrinsically resistant to drugs that thwarts currently available treatment regimes makes diseases difficult and, sometimes, impossible to treat in hospitals and the community settings.</p><p>An extensive increase in antibiotic resistance owed to a sustained persistence of resistant bacteria is becoming a serious threat for public health worldwide. The situation is aggravated by the decline in the production of drugs since the late 1960 s and by the long periods of time needed for testing new drugs before acceptance by the authorities for commercialization [<xref rid="B15-antibiotics-09-00480" ref-type="bibr">15</xref>]. Under these circumstances, there is a growing need for identifying alternatives to antibiotics in the prevention and treatment of microbial infections. One such approach is the utilization of naturally occurring botanicals that have the potential to be used as an alternative or a complement to antibiotics. Conventional curative systems have counted upon traditional herbs that are rich in compounds, such as alkaloids, terpenoids, tannins, steroids, coumarins and flavonoids [<xref rid="B16-antibiotics-09-00480" ref-type="bibr">16</xref>], and do not normally cause resistance [<xref rid="B17-antibiotics-09-00480" ref-type="bibr">17</xref>]. Essential oils (Eos) from parsley, lovage, basil and thyme disrupt the physiological status of the bacterial cell by causing an increase in cell permeability, leakage of cell constituents, alterations in bacterial cell wall and cell membrane, ATP loss, inhibition of protein synthesis, pH disturbance, intracytoplasmic damage, DNA damage and inhibition of quorum sensing among bacteria like <italic>Bacillus cereus</italic>, <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Escherichia. coli</italic> and <italic>Salmonella enterica</italic> serovar Typhimurium [<xref rid="B18-antibiotics-09-00480" ref-type="bibr">18</xref>,<xref rid="B19-antibiotics-09-00480" ref-type="bibr">19</xref>]. The present review summarizes the approaches for screening different phytochemicals, methods employed in the identification of bioactive components and their testing, strategies adopted along with the mechanistic insights of plant-derived substances (PDSs) in counteracting the lethal consequences of multidrug resistance.</p></sec><sec id="sec2-antibiotics-09-00480"><title>2. Isolation and Characterization of Bioactive Compounds</title><p>Different approaches are employed for screening the bioactive constituents of PDSs. The direct method involves total chemical characterization of a plant species using approaches of dereplication (identification of already known bioactive constituents) via liquid chromatography&#x02013;mass spectrometry (LC&#x02013;MS). The objective is to isolate novel plant compounds, which are then sent directly for biologic testing [<xref rid="B20-antibiotics-09-00480" ref-type="bibr">20</xref>,<xref rid="B21-antibiotics-09-00480" ref-type="bibr">21</xref>,<xref rid="B22-antibiotics-09-00480" ref-type="bibr">22</xref>,<xref rid="B23-antibiotics-09-00480" ref-type="bibr">23</xref>,<xref rid="B24-antibiotics-09-00480" ref-type="bibr">24</xref>]. Isolated plant compounds are collected for libraries, such as the National Cancer Institute&#x02019;s Natural Product Repository [<xref rid="B25-antibiotics-09-00480" ref-type="bibr">25</xref>]. Libraries can be screened to test the bioactivities of various compounds in order to examine fully characterized, new natural products [<xref rid="B26-antibiotics-09-00480" ref-type="bibr">26</xref>,<xref rid="B27-antibiotics-09-00480" ref-type="bibr">27</xref>,<xref rid="B28-antibiotics-09-00480" ref-type="bibr">28</xref>]. Bioactivity-guided fractionation method uses bioassays as fractionation monitors; uninterrupted fractionation cycles are used together for testing bioactive extracts so that pure and active principle compounds are isolated. This is the most commonly used way of determining bioactives. Despite significant increase in the number of studies reporting bioactives [<xref rid="B29-antibiotics-09-00480" ref-type="bibr">29</xref>,<xref rid="B30-antibiotics-09-00480" ref-type="bibr">30</xref>,<xref rid="B31-antibiotics-09-00480" ref-type="bibr">31</xref>,<xref rid="B32-antibiotics-09-00480" ref-type="bibr">32</xref>] through this process, a large number of botanicals and their preparations are still in use without any knowledge of their bioactives [<xref rid="B33-antibiotics-09-00480" ref-type="bibr">33</xref>,<xref rid="B34-antibiotics-09-00480" ref-type="bibr">34</xref>,<xref rid="B35-antibiotics-09-00480" ref-type="bibr">35</xref>,<xref rid="B36-antibiotics-09-00480" ref-type="bibr">36</xref>]. The synergy directed fractionation method uses bioactivity-guided fractionation combined with bioactivity testing in order to understand synergistic connections between the compounds present in a mixture. The method uses mass spectrometry (MS)-profiling for a guided isolation of natural products, targeting the synergistic interactions among obtained extracts which could not have been taken into consideration through conventional guided fractionation [<xref rid="B37-antibiotics-09-00480" ref-type="bibr">37</xref>,<xref rid="B38-antibiotics-09-00480" ref-type="bibr">38</xref>,<xref rid="B39-antibiotics-09-00480" ref-type="bibr">39</xref>,<xref rid="B40-antibiotics-09-00480" ref-type="bibr">40</xref>,<xref rid="B41-antibiotics-09-00480" ref-type="bibr">41</xref>]. Metabolism directed method is focused on the identification of bioactive metabolites not present at the beginning of the test, but produced with time due to changes in the metabolism of the plant or plant organ under study [<xref rid="B42-antibiotics-09-00480" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-09-00480" ref-type="bibr">43</xref>,<xref rid="B44-antibiotics-09-00480" ref-type="bibr">44</xref>,<xref rid="B45-antibiotics-09-00480" ref-type="bibr">45</xref>,<xref rid="B46-antibiotics-09-00480" ref-type="bibr">46</xref>,<xref rid="B47-antibiotics-09-00480" ref-type="bibr">47</xref>,<xref rid="B48-antibiotics-09-00480" ref-type="bibr">48</xref>,<xref rid="B49-antibiotics-09-00480" ref-type="bibr">49</xref>]. Additionally, metabolic profiling (metabolomics) method correlates chemical profiling of plant extracts with isolation and identification of new or already known bioactive constituents at an early stage (dereplication) [<xref rid="B50-antibiotics-09-00480" ref-type="bibr">50</xref>,<xref rid="B51-antibiotics-09-00480" ref-type="bibr">51</xref>]; the goal of metabolomics in general is to analyze all secondary metabolites in a sample, both qualitatively and quantitatively. Comparison of bioactivity data permits early stage dereplication. This method also gives information about possible synergistic effects between molecules [<xref rid="B52-antibiotics-09-00480" ref-type="bibr">52</xref>,<xref rid="B53-antibiotics-09-00480" ref-type="bibr">53</xref>,<xref rid="B54-antibiotics-09-00480" ref-type="bibr">54</xref>,<xref rid="B55-antibiotics-09-00480" ref-type="bibr">55</xref>,<xref rid="B56-antibiotics-09-00480" ref-type="bibr">56</xref>,<xref rid="B57-antibiotics-09-00480" ref-type="bibr">57</xref>,<xref rid="B58-antibiotics-09-00480" ref-type="bibr">58</xref>].</p></sec><sec id="sec3-antibiotics-09-00480"><title>3. Screening of PDSs for Drug Discovery</title><p>Plant materials are selected on the basis of habitual interactions between plants and the environment, taking into consideration that synthesized secondary metabolites may possess significant therapeutic benefits for humans. The screening of PDSs for drug discovery includes random, ethnopharmacological and computational approaches. Random selection of extracts is based on accessibility of plants and their enriched fractions. It unravels unexpected bioactivities that could have been missed based on the present knowledge [<xref rid="B59-antibiotics-09-00480" ref-type="bibr">59</xref>,<xref rid="B60-antibiotics-09-00480" ref-type="bibr">60</xref>,<xref rid="B61-antibiotics-09-00480" ref-type="bibr">61</xref>,<xref rid="B62-antibiotics-09-00480" ref-type="bibr">62</xref>,<xref rid="B63-antibiotics-09-00480" ref-type="bibr">63</xref>]. As pharmacological assays have medium to small throughput and the starting test samples (extracts, fractions or pure compounds) are available only in small amounts, the number of bioassays through which they can be tested is limited. The ethnopharmacological approach relies mainly on the traditional medicinal applications of plant species [<xref rid="B34-antibiotics-09-00480" ref-type="bibr">34</xref>,<xref rid="B64-antibiotics-09-00480" ref-type="bibr">64</xref>,<xref rid="B65-antibiotics-09-00480" ref-type="bibr">65</xref>,<xref rid="B66-antibiotics-09-00480" ref-type="bibr">66</xref>,<xref rid="B67-antibiotics-09-00480" ref-type="bibr">67</xref>]. This approach uses the observation, description and experimental investigation of traditionally used drugs and their bioactivities. It involves an interdisciplinary approach, including botany, biochemistry, chemistry, pharmacology and other fields beyond natural sciences like anthropology, archeology, history and linguistics [<xref rid="B68-antibiotics-09-00480" ref-type="bibr">68</xref>,<xref rid="B69-antibiotics-09-00480" ref-type="bibr">69</xref>,<xref rid="B70-antibiotics-09-00480" ref-type="bibr">70</xref>]. In computational approach, plant materials or natural products are selected based on the prediction of their bioactive constituents with a high likelihood for biologic activity. In addition, to predict characteristics of molecular structures like protein&#x02013;ligand biding interactions, in silico simulations can be used. Various computational approaches have been reported, such as the QSAR model (quantitative structure activity relationship); [<xref rid="B71-antibiotics-09-00480" ref-type="bibr">71</xref>,<xref rid="B72-antibiotics-09-00480" ref-type="bibr">72</xref>], which is used to predict compounds with high specificity for targets. Bioactivity databases, such as CHEMBL [<xref rid="B73-antibiotics-09-00480" ref-type="bibr">73</xref>] or PubChem [<xref rid="B74-antibiotics-09-00480" ref-type="bibr">74</xref>] are used to evaluate datasets for compatibility among naturally obtained products and synthetically obtained pharmacologically active molecules. The pharmacophore model [<xref rid="B75-antibiotics-09-00480" ref-type="bibr">75</xref>,<xref rid="B76-antibiotics-09-00480" ref-type="bibr">76</xref>] simulates 3D arrangements of molecules with different physicochemical features involved in the interactions between a ligand and its target. Meanwhile, molecular docking has a crucial function in defining drug&#x02013;protein interactions, helpful for determining whether plant extracts/compounds act as substrates for efflux pump proteins. Molecular docking suggests structure&#x02013;activity relationships of natural products for elucidating their mechanism of action and predicting the positioning of a ligand within a protein-binding pocket [<xref rid="B77-antibiotics-09-00480" ref-type="bibr">77</xref>].</p></sec><sec id="sec4-antibiotics-09-00480"><title>4. Bioassays for Phytochemical Testing</title><p>Gas chromatography&#x02013;mass spectrometry (GC&#x02013;MS) techniques are commonly used for the analysis of phytochemicals in plant extracts [<xref rid="B78-antibiotics-09-00480" ref-type="bibr">78</xref>,<xref rid="B79-antibiotics-09-00480" ref-type="bibr">79</xref>,<xref rid="B80-antibiotics-09-00480" ref-type="bibr">80</xref>,<xref rid="B81-antibiotics-09-00480" ref-type="bibr">81</xref>,<xref rid="B82-antibiotics-09-00480" ref-type="bibr">82</xref>]. Due to its high selectivity and sensitivity in the analysis of chemical constituents of plant origin, GC&#x02013;MS is considered as the gold standard for the elucidation of phytochemical profiles of plant extracts. In addition, agar macrodilution and microdilution methods are generally used to determine the minimum inhibitory concentration (MIC) of plant extracts against different bacterial isolates (<xref rid="antibiotics-09-00480-t001" ref-type="table">Table 1</xref>).</p><p>Though screening of phytochemicals for antimicrobial activity is usually done by the agar well diffusion method, time-kill assay and lysis experience, commonly employed bioassay methods and new methodologies adopted in drug discovery includes in vitro assays (based on purified proteins, cell and target oriented), in situ assay (assay with isolated tissues and organs) and in vivo assays with model organisms.</p><sec id="sec4dot1-antibiotics-09-00480"><title>4.1. In Vitro Assays </title><p>Assay with purified proteins relies on measuring either the pattern of interaction of a test compound with the target protein or the functional activity of the target protein in the presence of a test compound [<xref rid="B64-antibiotics-09-00480" ref-type="bibr">64</xref>] (<xref ref-type="fig" rid="antibiotics-09-00480-f001">Figure 1</xref>). Allowing high throughput screening, it does not require cell culture or animal facilities. The method has a limitation of showing unrelated interaction between protein and the compound being tested. Cell-based assay is used to verify the activity of compounds at the cellular level. It may also unveil molecular mechanisms underlying certain biologic effects, leading to new target molecule discovery or pathways affecting the respective phenotype [<xref rid="B64-antibiotics-09-00480" ref-type="bibr">64</xref>]. It provides medium to high throughput data and shows hits at the cellular level that are helpful in understanding the mechanisms of action involved and that can be used to discover novel molecular pathways to study concerned phenotypes. However, the method demands maintenance of the cell cultures and requires thorough knowledge and tedious efforts to reveal molecular targets affected in order to learn about the changed phenotypes and does not provide efficiency at in vivo level. Cell-based target oriented assay provokes the inhibition of a protein&#x02013;protein interaction to check the functional activity or the activation of a protein upon binding to a compound [<xref rid="B64-antibiotics-09-00480" ref-type="bibr">64</xref>]. The method provides knowledge of the molecular targets that helps in understanding the mechanism of action. It allows high throughput screening, demonstrating the efficiency of a target and giving information at a cellular level. The method has a prerequisite of cell culture and does not guarantee in vivo effectiveness of the compound being tested.</p></sec><sec id="sec4dot2-antibiotics-09-00480"><title>4.2. In Situ Assay with Isolated Tissues or Organs</title><p>The assay works at the interface of in vitro and in vivo models, encompassing an in situ method for isolated tissues or organs [<xref rid="B103-antibiotics-09-00480" ref-type="bibr">103</xref>,<xref rid="B104-antibiotics-09-00480" ref-type="bibr">104</xref>]. The method holds a high pathologic and physiological significance that reduces animal usage and allows high throughput in contrast to rodent models. However, the method provides low throughput in contrast to cell-based assays and have issues related to ethical clearance due to animal usage. Additionally, the isolated tissues and organs have a short ex vivo half-life.</p></sec><sec id="sec4dot3-antibiotics-09-00480"><title>4.3. In Vivo Assays Based on Model Organisms</title><p>Rodent models are employed for checking the in vivo efficacy of a drug, the discovery of new pharmacological targets and in the elucidation of the mechanisms of action of pharmacologically active compounds [<xref rid="B105-antibiotics-09-00480" ref-type="bibr">105</xref>,<xref rid="B106-antibiotics-09-00480" ref-type="bibr">106</xref>,<xref rid="B107-antibiotics-09-00480" ref-type="bibr">107</xref>]. Having high homology with respect to humans, the method promises of the high pathophysiological significance of hits in a whole organism. Limitations of the method include slow throughput, requirement of ethical clearance and demand of having animal facility. Much time is needed to follow-up the work until the identification of the targets at a molecular level is achieved. <italic>Caenorhabditis elegans</italic> and the zebrafish (non-mammalian animal models) are next in the usage due to their widespread availability and the existence of instruments that support high throughput screening [<xref rid="B108-antibiotics-09-00480" ref-type="bibr">108</xref>,<xref rid="B109-antibiotics-09-00480" ref-type="bibr">109</xref>]. Their applicability as disease models is further expanded by the recent implementation of gene editing techniques [<xref rid="B110-antibiotics-09-00480" ref-type="bibr">110</xref>]. These models are of high pathophysiological importance as they involve whole organisms. They could give rise to transgenic models. They require less amounts of the test substances in comparison to rodent models and are cost-effective. However, much time is needed to follow up on the work until the identification of the affected molecular target, besides detecting species-specific effects that are not relevant to humans. <italic>Galleria mellonella</italic> is used for the evaluation of pathogenesis and is used to study the potential of antimicrobial compounds. <italic>Galleria mellonella</italic> provides advantages of being used to test various bacterial species in a low time range with the cost-effectiveness manner. The management of this model comes easy. These qualities make <italic>Galleria mellonella</italic> an excellent model to check the in vivo efficacy of novel therapeutic remedies and simultaneously studying the host&#x02013;pathogen interactions. <italic>Galleria mellonella</italic> is still at its infancy because the procedures for this model are not fully standardized [<xref rid="B111-antibiotics-09-00480" ref-type="bibr">111</xref>].</p></sec></sec><sec id="sec5-antibiotics-09-00480"><title>5. Mechanistic Insights of Research on Botanicals</title><p>Plants synthesize a huge collection of structurally different compounds (polyphenols, terpenoids, essential oils, lectins, polypeptides and alkaloids), each having a specific and distinct role in the defense of the plant. Serving as potent contenders for future medicines, plant-based metabolites interfere with bacteria through different mechanisms. These are listed below.</p><sec id="sec5dot1-antibiotics-09-00480"><title>5.1. Inhibition of Cell Wall Synthesis</title><p>Peptidoglycan is composed of repeating units of <italic>N</italic>-acetylmuramic acid (NAcMur) and <italic>N</italic>-acetylglucosamine (NAcGlc) residues cross-linked by short chains of amino acids. The sequence of amino acid residues plays a crucial role in terms of providing strength, and as such, protection to bacteria [<xref rid="B112-antibiotics-09-00480" ref-type="bibr">112</xref>]. Plant-derived compounds have proved useful in the improvement of therapeutic methods to control the synthesis of the bacterial cell wall. The stamped antimicrobial property of flavonoids against an assortment of bacterial and contagious pathogens is attributed towards their action on the microbial cell wall [<xref rid="B113-antibiotics-09-00480" ref-type="bibr">113</xref>]. Their interaction with membrane proteins attached with bacterial cell walls prompts expanded membrane penetrability and disturbance. Quinone, for example&#x02014;anthraquinone from <italic>Cassia italica</italic>&#x02014;was observed to be bacteriostatic against pathogenic microbes like <italic>Bacillus anthracis</italic>, <italic>Corynebacterium pseudodiphthericum</italic> and <italic>Pseudomonas aeruginosa</italic> and bactericidal towards <italic>Burkholderia pseudomallei</italic>. Cell wall lysis has likewise been recorded in bacteria presented to phenolic mixes. Flavones, flavonoids and flavonols, their action is most likely because of their capacity to complex with bacterial cell walls along with the extracellular and dissolvable proteins (<xref rid="antibiotics-09-00480-t002" ref-type="table">Table 2</xref>).</p><p>Increasing lipophilic flavonoids may likewise upset bacterial membranes. Investigation with scanning electron microscopy (SEM), subsequent to applying the flavonoid glycosides, showed that <italic>Pseudomonas aeruginosa</italic> cells began to distort at 30 min. At 60 min, the cells were totally twisted, in this manner recommending that the system of activity is through framing pores in the cell wall and harming the cell wall [<xref rid="B126-antibiotics-09-00480" ref-type="bibr">126</xref>]. Tannins have properties that repress the development and protease action of ruminal microorganisms by targeting cell wall of bacteria. They could likewise disturb cell layers if lipophilic enough [<xref rid="B127-antibiotics-09-00480" ref-type="bibr">127</xref>]. Alkaloids for the most part display antimicrobial action through intercalating into the cell wall and DNA of bacteria. At the point when galangin was joined with amoxicillin, transmission electron microscopy uncovered the detachment of the external membrane of the cells; a conceivable instrument is harm to the inside peptidoglycan layer. Amoxicillin and kaempferide or kaempferide-3-O&#x02013;B-D-glucoside had an expanded hole between the external and cytoplasmic layers. These cells additionally exhibited morphologic harm to the cell wall and its shape. A few bacteria had broken cell walls. Amoxicillin or flavonoids alone were unfit to adjust the penetrability of the external layer as opposed to their blends. The impacts of consolidating amoxicillin and kaempferide or kempferide-3-O&#x02013;B-D-glucoside were more powerful than amoxicillin and galangin [<xref rid="B128-antibiotics-09-00480" ref-type="bibr">128</xref>,<xref rid="B129-antibiotics-09-00480" ref-type="bibr">129</xref>]. Increment in porousness of membrane and disturbance is seen because of their association with bacterial cell wall as well as with membrane proteins present on it (<xref ref-type="fig" rid="antibiotics-09-00480-f002">Figure 2</xref>).</p></sec><sec id="sec5dot2-antibiotics-09-00480"><title>5.2. Inhibition of Bacterial Physiology</title><p>Though the mechanisms of action of plant-derived substances (PDSs) is not clear, it is believed that they interfere with the organization of the cellular membrane leading to a diminished membrane potential and lower levels of ATP synthesis. Addition of PDSs to the medium causes changes in membrane permeability, metal ion chelation and disruption in the activity of membrane-bound ATPase that changes the physiological state of the bacteria and resulting in bacterial death [<xref rid="B130-antibiotics-09-00480" ref-type="bibr">130</xref>,<xref rid="B131-antibiotics-09-00480" ref-type="bibr">131</xref>,<xref rid="B132-antibiotics-09-00480" ref-type="bibr">132</xref>,<xref rid="B133-antibiotics-09-00480" ref-type="bibr">133</xref>,<xref rid="B134-antibiotics-09-00480" ref-type="bibr">134</xref>,<xref rid="B135-antibiotics-09-00480" ref-type="bibr">135</xref>]. It has been observed that thymol, carvacrol, catechins and eugenol disrupt the membrane structure and cause the discharge of cellular components, leading to depletion of cellular ATP [<xref rid="B132-antibiotics-09-00480" ref-type="bibr">132</xref>,<xref rid="B133-antibiotics-09-00480" ref-type="bibr">133</xref>,<xref rid="B134-antibiotics-09-00480" ref-type="bibr">134</xref>,<xref rid="B135-antibiotics-09-00480" ref-type="bibr">135</xref>]. Cinnamaldehyde also provokes a depletion of intracellular ATP by hampering ATPase-dependent metabolism, besides inhibiting glucose uptake and consumption [<xref rid="B132-antibiotics-09-00480" ref-type="bibr">132</xref>,<xref rid="B133-antibiotics-09-00480" ref-type="bibr">133</xref>,<xref rid="B134-antibiotics-09-00480" ref-type="bibr">134</xref>,<xref rid="B135-antibiotics-09-00480" ref-type="bibr">135</xref>]. Moreover, tea tree oil, composed of terpenes, monoterpenes, sesquiterpenes and the alcohols 1,8-cineol, &#x003b1;-terpineol and terpinen-4-ol, has the capacity to disrupt membrane permeability, damage cell membrane and obstruct cell growth, causing cell death in resistant microbes, like <italic>Escherichia coli</italic>, <italic>Staphylococcus aureus</italic> and <italic>Candida albicans</italic> [<xref rid="B136-antibiotics-09-00480" ref-type="bibr">136</xref>].</p></sec><sec id="sec5dot3-antibiotics-09-00480"><title>5.3. Modulation of Antibiotic Susceptibility</title><p>Researchers has discovered that PDSs have a built-in antimicrobial potency and can be effective as resistance modulating compounds. Geraniol, an essential oil from <italic>Helichrysum italicum</italic>, can reinstate the efficiency of chloramphenicol, quinolones and &#x003b2;-lactams towards multidrug resistant bacteria <italic>Acinetobacter baumannii</italic> [<xref rid="B137-antibiotics-09-00480" ref-type="bibr">137</xref>]. Comparable synergism was seen among antibiotics and several medicinal plant extracts, such as those from <italic>Camellia sinensis</italic> [<xref rid="B138-antibiotics-09-00480" ref-type="bibr">138</xref>] and <italic>Cesalpinia spinosa</italic> [<xref rid="B139-antibiotics-09-00480" ref-type="bibr">139</xref>], the oil of <italic>Croton zehntneri</italic> [<xref rid="B140-antibiotics-09-00480" ref-type="bibr">140</xref>] and compounds like carvacrol [<xref rid="B141-antibiotics-09-00480" ref-type="bibr">141</xref>] and baicalein derived from <italic>Scutellaria baicalensis</italic> [<xref rid="B142-antibiotics-09-00480" ref-type="bibr">142</xref>].</p><p>The control mechanisms of plant compounds for bacteria are being studied due to their participation in reducing the effect of strategies used by bacteria to combat the effects of antibiotics (including enzymatic degradation and alteration of target sites and efflux pumps (EPs) [<xref rid="B143-antibiotics-09-00480" ref-type="bibr">143</xref>]. Moreover, the combination of antibiotics and PDSs may be used in therapies to inhibit many pathways required for normal bacterial infection mechanisms and for reducing the synthesis of bacterial virulence factors. While extracts from <italic>Bridelia micrantha</italic> and <italic>Garcinia lucida</italic> restrict activity of &#x003b2;-lactamases [<xref rid="B144-antibiotics-09-00480" ref-type="bibr">144</xref>], inhibition of the penicillinase activity by epigallocatechin gallate from green tea in methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) restores antibacterial properties of both penicillin and ampicillin [<xref rid="B145-antibiotics-09-00480" ref-type="bibr">145</xref>]. As several PDSs were found having an inhibitory effect on EPs, investigations on eugenol, &#x003b2;-resorcylic acid, trans-cinnamaldehyde, thymol and carvacrol (individually, as well as in different combination) showed that they increased the sensitivity of <italic>Salmonella enterica</italic> serovar <italic>Typhimurium</italic> DT104 towards five antibiotics [<xref rid="B146-antibiotics-09-00480" ref-type="bibr">146</xref>].</p><p>Although the essential oils (EOs) of <italic>Chrysanthemum coronarium</italic> L. have no activity against <italic>Escherichia coli</italic>, <italic>Staphylococcus aureus</italic> or <italic>Pseudomonas aeruginosa</italic>, its application together with ticarcillin, imipenem, gentamicin and tobramycin in culture media results in a decrease in the antimicrobial activity of these antibiotics against most bacteria tested;, but a synergistic effect was also detected against some other bacteria [<xref rid="B147-antibiotics-09-00480" ref-type="bibr">147</xref>,<xref rid="B148-antibiotics-09-00480" ref-type="bibr">148</xref>]. Furthermore, as antimicrobial resistance in <italic>Salmonella enterica</italic> serovar <italic>Typhimurium</italic> DT104 is attributed to the interaction of antibiotic transporters with the efflux system AcrAB&#x02013;TolC, it becomes speculative to think that the modulation of EPs by PDSs makes pathogenic bacteria sensitive towards antibiotics.</p></sec><sec id="sec5dot4-antibiotics-09-00480"><title>5.4. Biofilms Inhibition</title><p>Biofilms are an assembly of surface-integrated microbial populations enclosing an exopolysaccharide matrix [<xref rid="B149-antibiotics-09-00480" ref-type="bibr">149</xref>]. Biofilm formation is a worrisome situation both in hospital environments and the food industry [<xref rid="B150-antibiotics-09-00480" ref-type="bibr">150</xref>,<xref rid="B151-antibiotics-09-00480" ref-type="bibr">151</xref>,<xref rid="B152-antibiotics-09-00480" ref-type="bibr">152</xref>,<xref rid="B153-antibiotics-09-00480" ref-type="bibr">153</xref>,<xref rid="B154-antibiotics-09-00480" ref-type="bibr">154</xref>]. Comprehensive research investigating alternative plans to stop microbial biofilm formation has emphasized on the effectiveness of PDSs in limiting biofilm formation by important pathogens like <italic>Listeria monocytogenes</italic> [<xref rid="B155-antibiotics-09-00480" ref-type="bibr">155</xref>], <italic>Staphylococcus aureus</italic> [<xref rid="B156-antibiotics-09-00480" ref-type="bibr">156</xref>,<xref rid="B157-antibiotics-09-00480" ref-type="bibr">157</xref>,<xref rid="B158-antibiotics-09-00480" ref-type="bibr">158</xref>,<xref rid="B159-antibiotics-09-00480" ref-type="bibr">159</xref>,<xref rid="B160-antibiotics-09-00480" ref-type="bibr">160</xref>], <italic>Pseudomonas aeruginosa</italic> [<xref rid="B161-antibiotics-09-00480" ref-type="bibr">161</xref>,<xref rid="B162-antibiotics-09-00480" ref-type="bibr">162</xref>], <italic>Escherichia coli</italic> [<xref rid="B163-antibiotics-09-00480" ref-type="bibr">163</xref>,<xref rid="B164-antibiotics-09-00480" ref-type="bibr">164</xref>] and <italic>Klebsiella pneumoniae.</italic> PDSs, at sub-inhibitory concentrations, cause changes in the transcription of genes critical for biofilm formation, thereby contributing to antibiofilm activity [<xref rid="B165-antibiotics-09-00480" ref-type="bibr">165</xref>,<xref rid="B166-antibiotics-09-00480" ref-type="bibr">166</xref>,<xref rid="B167-antibiotics-09-00480" ref-type="bibr">167</xref>,<xref rid="B168-antibiotics-09-00480" ref-type="bibr">168</xref>,<xref rid="B169-antibiotics-09-00480" ref-type="bibr">169</xref>,<xref rid="B170-antibiotics-09-00480" ref-type="bibr">170</xref>]. In a study, Brackman and coworkers (2008) reported inhibitory effects of <italic>trans</italic>-cinnamaldehyde on biofilm formation among <italic>Vibrio</italic> spp. [<xref rid="B171-antibiotics-09-00480" ref-type="bibr">171</xref>]. Although <italic>trans</italic>-cinnamaldehyde is competent enough to diminish autoinducer-2-dependent quorum sensing and biofilm production through the transcriptional regulation of specific genes, comparable transcription modulatory effects without disturbing bacterial growth have been seen in <italic>Salmonella</italic> [<xref rid="B172-antibiotics-09-00480" ref-type="bibr">172</xref>] and <italic>Pseudomonas aeruginosa</italic> [<xref rid="B173-antibiotics-09-00480" ref-type="bibr">173</xref>]. <italic>Trans</italic>-cinnamaldehyde also controls biofilm development and halts completely grown biofilms of <italic>Cronobacter sakazakii</italic>, found on stainless steel surfaces and feeding bottles and uropathogenic <italic>Escherichia coli</italic> present in urinary catheters [<xref rid="B165-antibiotics-09-00480" ref-type="bibr">165</xref>,<xref rid="B174-antibiotics-09-00480" ref-type="bibr">174</xref>]. Equally, terpenes like carvacrol, geraniol, thymol and EOs, exhibit potent antibiofilm activity against diverse bacterial and fungal biofilms [<xref rid="B175-antibiotics-09-00480" ref-type="bibr">175</xref>,<xref rid="B176-antibiotics-09-00480" ref-type="bibr">176</xref>,<xref rid="B177-antibiotics-09-00480" ref-type="bibr">177</xref>]. As quorum sensing regulates the expression of genes associated with the production of virulence factors [<xref rid="B178-antibiotics-09-00480" ref-type="bibr">178</xref>,<xref rid="B179-antibiotics-09-00480" ref-type="bibr">179</xref>,<xref rid="B180-antibiotics-09-00480" ref-type="bibr">180</xref>], focus has been given to PDSs that interfere with cell-to-cell communication, as anti-quorum-sensing molecules, which cause a decrease in the expression of virulence genes [<xref rid="B181-antibiotics-09-00480" ref-type="bibr">181</xref>,<xref rid="B182-antibiotics-09-00480" ref-type="bibr">182</xref>,<xref rid="B183-antibiotics-09-00480" ref-type="bibr">183</xref>]. For example, the expression of <italic>luxR</italic> (a transcriptional regulator of quorum sensing) in <italic>C. sakazakii</italic> shows a decreasing trend in response to application of <italic>trans</italic>-cinnamaldehyde [<xref rid="B165-antibiotics-09-00480" ref-type="bibr">165</xref>]. Additionally, Bodini and coworkers (2009) reported the antiquorum sensing properties of <italic>p</italic>-coumaric acid and garlic extracts [<xref rid="B184-antibiotics-09-00480" ref-type="bibr">184</xref>]. Moreover, goldenseal, a PDS from <italic>Hydrastis canadensis</italic> L., disrupts microbial quorum sensing activity by interfering with the AgrCA two-component system in MRSA [<xref rid="B185-antibiotics-09-00480" ref-type="bibr">185</xref>]. <italic>Streptococcus pneumoniae</italic> forms orderly biofilms that show persistence in human nasopharynx, permitting the development of diseases, such as pneumonia, otitis media, bacteremia and meningitis. Treating <italic>Streptococcus pneumoniae</italic> with 220D-F2, a plant extract from <italic>Rubus ulmifolius</italic>, in combination with ellagic acid and its derivatives showed a dose-dependent inhibition of biofilm formation [<xref rid="B186-antibiotics-09-00480" ref-type="bibr">186</xref>]. Studies on bacterial viability following treatment with 100&#x02013;200 mg/mL of 220D-F2 showed bactericidal effects as early as 3 h post inoculation for <italic>Streptococcus pneumoniae</italic>. Minimum inhibitory concentration (MIC) studies revealed that 80 mg/mL of 220D-F2 eliminates antibiotic resistant pneumococci strains. Testing essential oils from different plant sources, such as <italic>Origanum vulgare</italic>, <italic>Mentha piperita</italic> and <italic>Hofmeisteria schaffneri</italic>, against <italic>S. aureus</italic> has shown significant inhibitory activity. Studies on the antibiofilm activity of EOs and solvent extracts of different plants, such as <italic>Mentha piperita</italic>, <italic>Pimpinella anisum</italic> and <italic>Coriandrum sativum</italic>, revealed interference with the attachment of bacteria (<italic>Staphylococcus aureus</italic>, <italic>Escherichia coli</italic> and others) to the host tissues [<xref rid="B187-antibiotics-09-00480" ref-type="bibr">187</xref>]. A potent antibiofilm activity against <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> was observed for coriander oil at concentrations of 0.8 and 1.6 mg/mL. Non-accountable for the rise in antimicrobial resistance, carvacrol exerts an inhibitory effect, through interference with biofilm formation, against <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic> [<xref rid="B156-antibiotics-09-00480" ref-type="bibr">156</xref>,<xref rid="B167-antibiotics-09-00480" ref-type="bibr">167</xref>]. Essential oils from <italic>Citrus sinensis</italic>, <italic>Citrus bergamia</italic>, <italic>Sideritis erythrantha</italic> and <italic>Eucalyptus globulus</italic> were found to be effective in combating vancomycin-resistant enterococci (VRE) [<xref rid="B188-antibiotics-09-00480" ref-type="bibr">188</xref>,<xref rid="B189-antibiotics-09-00480" ref-type="bibr">189</xref>,<xref rid="B190-antibiotics-09-00480" ref-type="bibr">190</xref>,<xref rid="B191-antibiotics-09-00480" ref-type="bibr">191</xref>]. In addition, a study on the antibiofilm activity of the methanolic extracts of <italic>Sclero caryabirrea</italic> showed that, besides inhibiting the swarming capability of <italic>Pseudomonas aeruginosa</italic>, they disturb quorum-sensing-mediated biofilm formation. Moreover, the extracts also exerted regulatory effects on the secretion of pyoverdine and proteases (quorum sensing reliant pathogenic factors). Growth and biofilm inhibitory effects on <italic>Staphylococcus aureus</italic> have also been observed for extracts obtained from <italic>Quercus cerris</italic> [<xref rid="B192-antibiotics-09-00480" ref-type="bibr">192</xref>]. <italic>Staphylococcus aureus</italic> pathogenicity ranges from localized skin infection to systemic infection of different tissues. Finally, an antibiofilm activity of flavonoids from <italic>Vaccinium macrocarpon</italic>(cranberry) was identified against <italic>Enterococcus faecalis</italic>, <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> [<xref rid="B193-antibiotics-09-00480" ref-type="bibr">193</xref>].</p></sec><sec id="sec5dot5-antibiotics-09-00480"><title>5.5. Attenuating Bacterial Virulence</title><p>The production of virulence determinants, like capsule polysaccharides, plays an important role in the development of virulence [<xref rid="B49-antibiotics-09-00480" ref-type="bibr">49</xref>] in bacteria like <italic>S. pneumoniae</italic> [<xref rid="B16-antibiotics-09-00480" ref-type="bibr">16</xref>,<xref rid="B194-antibiotics-09-00480" ref-type="bibr">194</xref>,<xref rid="B195-antibiotics-09-00480" ref-type="bibr">195</xref>] <italic>Staphylococcus aureus</italic> [<xref rid="B196-antibiotics-09-00480" ref-type="bibr">196</xref>], <italic>Klebsiella pneumoniae</italic> and <italic>Bacillus anthracis</italic>. The capsule protects bacteria from phagocytosis [<xref rid="B194-antibiotics-09-00480" ref-type="bibr">194</xref>]; thus, improving bacterial growth within the host [<xref rid="B196-antibiotics-09-00480" ref-type="bibr">196</xref>]. Apart from virulence, the existence of a capsule helps in biofilm production and adhesion [<xref rid="B197-antibiotics-09-00480" ref-type="bibr">197</xref>,<xref rid="B198-antibiotics-09-00480" ref-type="bibr">198</xref>]. Capsule formation can lead to pathology even in plants; capsular polysaccharides of <italic>Pseudomonas solanacearum</italic>, for example, occlude xylem vessels of plants eventually causing the plant&#x02019;s death. Foodborne pathogens adhere to the intestinal epithelium and invade through a receptor-mediated mechanism involving the surface proteins InlA and InlB; the presence of PDSs was found to decrease virulence factor production in <italic>Listeria monocytogenes</italic> [<xref rid="B169-antibiotics-09-00480" ref-type="bibr">169</xref>], uropathogenic <italic>Escherichia coli</italic> [<xref rid="B165-antibiotics-09-00480" ref-type="bibr">165</xref>] and <italic>Salmonella enterica</italic> serovar Enteritidis [<xref rid="B199-antibiotics-09-00480" ref-type="bibr">199</xref>], reducing their invasion capacity. Additionally, capsular polysaccharides, necessary for pathogen survival inside the host, showed a reduction following exposure to PDSs [<xref rid="B200-antibiotics-09-00480" ref-type="bibr">200</xref>]. Furthermore, various derivatives of salicylic acid, which is a signal molecule involved in plant protection [<xref rid="B201-antibiotics-09-00480" ref-type="bibr">201</xref>], including sodium salicylate, bismuth subsalicylate and bismuth dimercaprol [<xref rid="B202-antibiotics-09-00480" ref-type="bibr">202</xref>], were shown to regulate the construction of bacterial capsules. Further studies on these derivatives revealed that salicylic acid is efficient in reducing capsule manufacturing by regulating the expression of bacterial regulators of the capsule synthesis in <italic>Staphylococcus aureus</italic>. As quorum sensing, adhesion and capsular polysaccharides play a vital role for interaction among microbes and flourishment within the host, it becomes imperative to exploit them for therapeutics for overcoming the burden of increasing antibiotic resistance among microbes.</p></sec></sec><sec id="sec6-antibiotics-09-00480"><title>6. Hurdles to Overcome</title><p>Regardless of their antimicrobial effects, the use of PDSs as alternatives or complements (either for increasing the activity or decreasing the dose) to antibiotics is impeded by regulatory factors that pose a challenge regarding their implementation in the treatment of diseases. One challenge is the development of effective extraction and purification systems for the isolation of newer and safer plant-derived antimicrobials [<xref rid="B203-antibiotics-09-00480" ref-type="bibr">203</xref>]. In addition to solvent extractions systems, microwave and ultrasonic-assisted extraction methods are currently being explored for the extraction of PDSs [<xref rid="B204-antibiotics-09-00480" ref-type="bibr">204</xref>]. Screening bioactive compounds for elucidating their structure, function and action mechanisms is necessary to fine tune their production and maximize their performance with simplicity, specificity and speed. Isolation and purification processes have been accelerated with the development of high-pressure liquid chromatography (HPLC) and a variety of spectroscopic techniques (UV-visible, infrared (IR), nuclear magnetic resonance (NMR) and mass spectroscopy [<xref rid="B205-antibiotics-09-00480" ref-type="bibr">205</xref>]. Additionally, reduction in the production cost can be achieved by rationalizing their chemical synthesis and further increasing their efficacy by modifying their structures. To properly address the feasibility of the use of PSDs, the following points need to be considered: (1) dose in terms of bacteriostatic/-cidal effect; (2) variation in phytochemical constituents; (3) safety in humans; and (4) efficacy without any concurrent effect in terms of resistance development. A deeper insight into the toxicity of PDSs, their mechanism of action and influential interactions with antibiotics needs further exploration to have a complete understanding of their role in disease treatment and for their broader adoption in the near future. A recent strategic approach, using fluorescently labeled antibiotics, promises good results in resistance and toxicological studies and in elucidating the potency of PDSs in the treatment of different diseases [<xref rid="B206-antibiotics-09-00480" ref-type="bibr">206</xref>]. Though much attention has been paid to adding flexibility to approval strategies, consistency in safety, efficacy and delivery methods is required for their commercialized use against broad range of pathogens.</p></sec><sec sec-type="conclusions" id="sec7-antibiotics-09-00480"><title>7. Conclusions</title><p>The phenomenon of antibiotic resistance is not only old but is also a very difficult situation that emerges among bacteria exposed to antibiotics. Sadly, it has not been given a priority even though it has become a serious issue concerning human health. This worrisome situation is continuously growing, but still, it has not been included in planning strategies among health experts, the scientific community or researchers. The current crisis of rising multidrug resistance in bacteria is creating a global threat, necessitating the development of new alternatives. With the relative absence of new antimicrobials in the market, the sleeping giants of the pharmaceutical industry (medicinal herbs) have high potential for being a source of natural drugs that can be utilized to combat the menace created by antibiotic resistance. Plant-based antimicrobials have a potential for use in the manufacturing of drugs. Exhibiting a potent antimicrobial activity, plant-based antimicrobials, either alone or combined with antibiotics, can help in dealing with the present crisis of antibiotic resistance. A study by Carradori et al. shows antimicrobial activity of <italic>Crocus sativus-derived</italic> compounds against different bacterial sp. [<xref rid="B207-antibiotics-09-00480" ref-type="bibr">207</xref>]. This study shows the promising antimicrobial activity from the modified compounds of <italic>Crocus sativus.</italic> The MIC values obtained in a particular activity were showing synergy among <italic>Crocus sativus</italic> components. These kinds of studies provide an insight that certain chemical and structural modifications can provide us with more promising and effective compounds that can help in the formulation of innovative drugs to fight against antifungal and antimicrobial situation. In conclusion, there is an urgent requirement to develop plant-based antimicrobials to counteract antibiotic resistance. The search for natural compounds, extracted from medicinal plants, is a necessity. Research based on ethnopharmacology the field of study that uses plant herbs as a therapeutic option, may be used as a guide in our search for suitable agents against the spread of antibiotic resistance. The global nature of this crisis and its substantial health and economic burdens prompt us to urgently identify new alternatives as well as implement new policies to combat antibiotic resistance.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to the support provided by King Saud University, Riyadh, Saudi Arabia, Indian Council of Medical Research (ICMR), India for fellowship to I.S., and University Grants Commission (UGC), India for startup grant to A.T.J.</p></ack><notes><title>Author Contributions</title><p>A.T.J. and Q.M.R.H. conceived the idea. H.M.A.A., I.S. and V.K. contributed to the writing of the manuscript. H.A.-S. contributed to review of literature, A.T.J. and I.A.R. edited the manuscript and design figures. A.T.J. and Q.M.R.H. reviewed and approved the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>No funding was availed for the study.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-09-00480"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>World Health Organization Model List of Essential Medicines</source><comment>amended August 2017; 20th List</comment><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><month>3</month><year>2017</year></element-citation></ref><ref id="B2-antibiotics-09-00480"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunphy</surname><given-names>L.J.</given-names></name><name><surname>Yen</surname><given-names>P.</given-names></name><name><surname>Papin</surname><given-names>J.A.</given-names></name></person-group><article-title>Integrated experimental and computational analyses reveal differential metabolic functionality in antibiotic-resistant <italic>Pseudomonas aeruginosa</italic></article-title><source>Cell Syst.</source><year>2019</year><volume>8</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.12.002</pub-id><?supplied-pmid 30611675?><pub-id pub-id-type="pmid">30611675</pub-id></element-citation></ref><ref id="B3-antibiotics-09-00480"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoiby</surname><given-names>N.</given-names></name><name><surname>Bjarnsholt</surname><given-names>T.</given-names></name><name><surname>Givskov</surname><given-names>M.</given-names></name><name><surname>Molin</surname><given-names>S.</given-names></name><name><surname>Ciofu</surname><given-names>O.</given-names></name></person-group><article-title>Antibiotic resistance of bacterial biofilms</article-title><source>Int. J. Antimicrob. Agents</source><year>2010</year><volume>35</volume><fpage>322</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.12.011</pub-id><?supplied-pmid 20149602?><pub-id pub-id-type="pmid">20149602</pub-id></element-citation></ref><ref id="B4-antibiotics-09-00480"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>A.</given-names></name><name><surname>Magana</surname><given-names>M.</given-names></name><name><surname>Bologa</surname><given-names>C.G.</given-names></name><name><surname>Oprea</surname><given-names>T.I.</given-names></name><name><surname>Paulsen</surname><given-names>I.T.</given-names></name><name><surname>Tegos</surname><given-names>G.P.</given-names></name></person-group><article-title>Defining the microbial effluxome in the content of the host-microbiome interaction</article-title><source>Front. Pharm.</source><year>2015</year><volume>6</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.3389/fphar.2015.00031</pub-id><?supplied-pmid 25745401?><pub-id pub-id-type="pmid">25745401</pub-id></element-citation></ref><ref id="B5-antibiotics-09-00480"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lister</surname><given-names>P.D.</given-names></name><name><surname>Wolter</surname><given-names>D.J.</given-names></name><name><surname>Hanson</surname><given-names>N.D.</given-names></name></person-group><article-title>Antibacterial-resistant <italic>Pseudomonas aeruginosa</italic>: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms</article-title><source>Clin. Microbiol. Rev.</source><year>2009</year><volume>22</volume><fpage>582</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1128/CMR.00040-09</pub-id><?supplied-pmid 19822890?><pub-id pub-id-type="pmid">19822890</pub-id></element-citation></ref><ref id="B6-antibiotics-09-00480"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>Z.</given-names></name><name><surname>Raudonis</surname><given-names>R.</given-names></name><name><surname>Glick</surname><given-names>B.R.</given-names></name><name><surname>Lin</surname><given-names>T.J.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name></person-group><article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic>: Mechanisms and alternative therapeutic strategies</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id><pub-id pub-id-type="pmid">30500353</pub-id></element-citation></ref><ref id="B7-antibiotics-09-00480"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reygaert</surname><given-names>W.C.</given-names></name></person-group><article-title>An overview of the antimicrobial resistance mechanisms of bacteria</article-title><source>AIMS Microbiol.</source><year>2018</year><volume>4</volume><fpage>482</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.3934/microbiol.2018.3.482</pub-id><pub-id pub-id-type="pmid">31294229</pub-id></element-citation></ref><ref id="B8-antibiotics-09-00480"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beceiro</surname><given-names>A.</given-names></name><name><surname>Tomas</surname><given-names>M.</given-names></name><name><surname>Bou</surname><given-names>G.</given-names></name></person-group><article-title>Antimicrobial resistance and virulence: A successful or deleterious association in the bacterial world?</article-title><source>Clin. Microbiol. Rev.</source><year>2013</year><volume>26</volume><fpage>185</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1128/CMR.00059-12</pub-id><pub-id pub-id-type="pmid">23554414</pub-id></element-citation></ref><ref id="B9-antibiotics-09-00480"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beighton</surname><given-names>D.</given-names></name></person-group><article-title>Can the ecology of the dental biofilm be beneficially altered?</article-title><source>Adv. Dent. Res.</source><year>2009</year><volume>21</volume><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1177/0895937409335641</pub-id><pub-id pub-id-type="pmid">19717412</pub-id></element-citation></ref><ref id="B10-antibiotics-09-00480"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunce</surname><given-names>J.T.</given-names></name><name><surname>Hellyer</surname><given-names>P.</given-names></name></person-group><article-title>Antibiotic resistance and antibiotic prescribing by dentists in England 2007&#x02013;2016</article-title><source>Br. Dent. J.</source><year>2018</year><volume>225</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/sj.bdj.2018.525</pub-id><pub-id pub-id-type="pmid">30002521</pub-id></element-citation></ref><ref id="B11-antibiotics-09-00480"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrini</surname><given-names>L.</given-names></name><name><surname>Monaco</surname><given-names>A.</given-names></name><name><surname>Pietropaoli</surname><given-names>D.</given-names></name><name><surname>Ortu</surname><given-names>E.</given-names></name><name><surname>Giannoni</surname><given-names>M.</given-names></name><name><surname>Marci</surname><given-names>M.C.</given-names></name></person-group><article-title>Antibiotics in dentistry: A narrative review of literature and guidelines considering antibiotic resistance</article-title><source>Open Dent. J.</source><year>2019</year><volume>13</volume><fpage>383</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.2174/1874210601913010383</pub-id></element-citation></ref><ref id="B12-antibiotics-09-00480"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>R.</given-names></name><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Goyal</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>T.</given-names></name><name><surname>Sood</surname><given-names>H.</given-names></name><name><surname>Malviya</surname><given-names>H.S.</given-names></name></person-group><article-title>Antibiotic abuse during endodontic treatment: A contributing factor to antibiotic resistance</article-title><source>J. Fam. Med. Prim. Care</source><year>2019</year><volume>8</volume><fpage>3518</fpage><lpage>3524</lpage><pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_768_19</pub-id><?supplied-pmid 31803645?><pub-id pub-id-type="pmid">31803645</pub-id></element-citation></ref><ref id="B13-antibiotics-09-00480"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>M.</given-names></name><name><surname>Sartelli</surname><given-names>M.</given-names></name><name><surname>Haque</surname><given-names>S.Z.</given-names></name></person-group><article-title>Dental infection and resistance-global health consequences</article-title><source>Dent. J.</source><year>2019</year><volume>7</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.3390/dj7010022</pub-id><?supplied-pmid 30823670?><pub-id pub-id-type="pmid">30823670</pub-id></element-citation></ref><ref id="B14-antibiotics-09-00480"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Ren</surname><given-names>B.</given-names></name></person-group><article-title>Application of antibiotics/antimicrobial agents on dental caries</article-title><source>Biomed. Res. Int.</source><year>2020</year><volume>2020</volume><fpage>5658212</fpage><pub-id pub-id-type="doi">10.1155/2020/5658212</pub-id><?supplied-pmid 32076608?><pub-id pub-id-type="pmid">32076608</pub-id></element-citation></ref><ref id="B15-antibiotics-09-00480"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spellberg</surname><given-names>B.</given-names></name><name><surname>Powers</surname><given-names>J.H.</given-names></name><name><surname>Brass</surname><given-names>E.P.</given-names></name><name><surname>Miller</surname><given-names>L.G.</given-names></name><name><surname>Edwards</surname><given-names>J.E.J.</given-names></name></person-group><article-title>Trends in antimicrobial drug development: Implications for the future</article-title><source>Clin. Infect. Dis.</source><year>2004</year><volume>38</volume><fpage>1279</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1086/420937</pub-id><pub-id pub-id-type="pmid">15127341</pub-id></element-citation></ref><ref id="B16-antibiotics-09-00480"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yother</surname><given-names>J.</given-names></name></person-group><article-title>Capsules of <italic>Streptococcus pneumoniae</italic> and other bacteria: Paradigms for polysaccharide biosynthesis and regulation</article-title><source>Annu. Rev. Microbiol.</source><year>2011</year><volume>65</volume><fpage>563</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.62.081307.162944</pub-id><pub-id pub-id-type="pmid">21721938</pub-id></element-citation></ref><ref id="B17-antibiotics-09-00480"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K.</given-names></name><name><surname>Ausubel</surname><given-names>F.M.</given-names></name></person-group><article-title>Prospects for plant-derived antibacterials</article-title><source>Nat. Biotechnol.</source><year>2006</year><volume>24</volume><fpage>1504</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1038/nbt1206-1504</pub-id><pub-id pub-id-type="pmid">17160050</pub-id></element-citation></ref><ref id="B18-antibiotics-09-00480"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolli</surname><given-names>M.E.</given-names></name><name><surname>Laouer</surname><given-names>H.</given-names></name><name><surname>Kolli</surname><given-names>H.E.</given-names></name><name><surname>Akkal</surname><given-names>S.</given-names></name><name><surname>Sahli</surname><given-names>F.</given-names></name></person-group><article-title>Chemical analysis, antimicrobial and anti-oxidative properties of Daucus gracilis essential oil and its mechanism of action</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2016</year><volume>6</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2015.08.004</pub-id></element-citation></ref><ref id="B19-antibiotics-09-00480"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gemeda</surname><given-names>N.</given-names></name><name><surname>Tadele</surname><given-names>A.</given-names></name><name><surname>Lemma</surname><given-names>H.</given-names></name><name><surname>Girma</surname><given-names>B.</given-names></name><name><surname>Addis</surname><given-names>G.</given-names></name><name><surname>Tesfaye</surname><given-names>B.</given-names></name><name><surname>Abebe</surname><given-names>A.</given-names></name><name><surname>Gemechu</surname><given-names>W.</given-names></name><name><surname>Yirsaw</surname><given-names>K.</given-names></name><name><surname>Teka</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Development, characterization, and evaluation of novel broad-spectrum antimicrobial topical formulations from <italic>Cymbopogon martini</italic> (Roxb.) W. watson essential oil</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2018</year><volume>2018</volume><fpage>9812093</fpage><pub-id pub-id-type="doi">10.1155/2018/9812093</pub-id></element-citation></ref><ref id="B20-antibiotics-09-00480"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appendino</surname><given-names>G.</given-names></name><name><surname>Scafati</surname><given-names>O.T.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name><name><surname>Pollastro</surname><given-names>F.</given-names></name><name><surname>Avonto</surname><given-names>C.</given-names></name><name><surname>Rubiolo</surname><given-names>P.</given-names></name></person-group><article-title>Genepolide, a sesterpene gamma-lactone with a novel carbon skeleton from mountain wormwood (<italic>Artemisia umbelliformis</italic>)</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>340</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1021/np800468m</pub-id><pub-id pub-id-type="pmid">19053512</pub-id></element-citation></ref><ref id="B21-antibiotics-09-00480"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname><given-names>J.</given-names></name><name><surname>Dinchev</surname><given-names>D.</given-names></name><name><surname>Klaiber</surname><given-names>I.</given-names></name><name><surname>Mika</surname><given-names>S.</given-names></name><name><surname>Kostova</surname><given-names>I.</given-names></name><name><surname>Kraus</surname><given-names>W.</given-names></name></person-group><article-title>A novel furostanol saponin from <italic>Tribulus terrestris</italic> of bulgarian origin</article-title><source>Fitoterapia</source><year>2004</year><volume>75</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2003.09.001</pub-id><pub-id pub-id-type="pmid">15030914</pub-id></element-citation></ref><ref id="B22-antibiotics-09-00480"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X.H.</given-names></name><name><surname>Fang</surname><given-names>F.F.</given-names></name><name><surname>Zheng</surname><given-names>C.J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>L.P.</given-names></name></person-group><article-title>Monoterpenoids from the whole herb of <italic>Veronicastrum axillare</italic></article-title><source>Pharm. Biol.</source><year>2014</year><volume>52</volume><fpage>661</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.3109/13880209.2013.863947</pub-id><?supplied-pmid 24405018?><pub-id pub-id-type="pmid">24405018</pub-id></element-citation></ref><ref id="B23-antibiotics-09-00480"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>J.Y.</given-names></name><name><surname>Cai</surname><given-names>P.L.</given-names></name><name><surname>Yang</surname><given-names>S.L.</given-names></name></person-group><article-title>New triterpenoid saponins from Patrinia scabiosaefolia</article-title><source>Carbohydr. Res.</source><year>2011</year><volume>346</volume><fpage>2881</fpage><lpage>2885</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2011.10.008</pub-id><?supplied-pmid 22050996?><pub-id pub-id-type="pmid">22050996</pub-id></element-citation></ref><ref id="B24-antibiotics-09-00480"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.X.</given-names></name><name><surname>Kang</surname><given-names>L.P.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>H.S.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Xiong</surname><given-names>C.Q.</given-names></name><name><surname>Ma</surname><given-names>B.P.</given-names></name></person-group><article-title>Two novel furostanol saponins from the tubers of <italic>Ophiopogon japonicus</italic></article-title><source>J. Asian Nat. Prod. Res.</source><year>2013</year><volume>15</volume><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1080/10286020.2013.783024</pub-id><?supplied-pmid 23600887?><pub-id pub-id-type="pmid">23600887</pub-id></element-citation></ref><ref id="B25-antibiotics-09-00480"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Hsieh</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>Y.L.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Peto</surname><given-names>C.</given-names></name><name><surname>Jablons</surname><given-names>D.M.</given-names></name><name><surname>You</surname><given-names>L.</given-names></name></person-group><article-title>Coumestrol from the national cancer institute&#x02019;s natural product library is a novel inhibitor of protein kinase CK2</article-title><source>BMC Pharm. Toxicol.</source><year>2013</year><volume>14</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.1186/2050-6511-14-36</pub-id></element-citation></ref><ref id="B26-antibiotics-09-00480"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramasamy</surname><given-names>D.</given-names></name><name><surname>Saraswathy</surname><given-names>A.</given-names></name></person-group><article-title>Vitiquinolone&#x02014;A quinolone alkaloid from <italic>Hibiscus vitifolius</italic> linn</article-title><source>Food Chem.</source><year>2014</year><volume>145</volume><fpage>970</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.08.128</pub-id><pub-id pub-id-type="pmid">24128571</pub-id></element-citation></ref><ref id="B27-antibiotics-09-00480"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.F.</given-names></name><name><surname>Zhang</surname><given-names>Z.X.</given-names></name><name><surname>Guo</surname><given-names>C.Y.</given-names></name><name><surname>Guo</surname><given-names>D.A.</given-names></name></person-group><article-title>A nobel cyanogenic glycoside from <italic>Semiaquilegia adoxoides</italic></article-title><source>J. Asian Nat. Prod. Res.</source><year>2005</year><volume>7</volume><fpage>171</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1080/10286020310001625148</pub-id><pub-id pub-id-type="pmid">15621622</pub-id></element-citation></ref><ref id="B28-antibiotics-09-00480"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedenfeld</surname><given-names>H.</given-names></name><name><surname>Dumaa</surname><given-names>M.</given-names></name><name><surname>Malinowski</surname><given-names>M.</given-names></name><name><surname>Furmanowa</surname><given-names>M.</given-names></name><name><surname>Narantuya</surname><given-names>S.</given-names></name></person-group><article-title>Phytochemical and analytical studies of extracts from <italic>Rhodiola rosea</italic> and <italic>Rhodiola quadrifida</italic></article-title><source>Pharmazie</source><year>2007</year><volume>62</volume><fpage>308</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">17484290</pub-id></element-citation></ref><ref id="B29-antibiotics-09-00480"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>P.</given-names></name><name><surname>Johnson</surname><given-names>T.S.</given-names></name><name><surname>Dethe</surname><given-names>S.M.</given-names></name><name><surname>Chandrasekaran</surname><given-names>C.</given-names></name></person-group><article-title>Use of in vitro bioassays for assessing botanicals</article-title><source>Curr. Opin. Biotechnol.</source><year>2014</year><volume>25</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2013.08.010</pub-id><?supplied-pmid 24484879?><pub-id pub-id-type="pmid">24484879</pub-id></element-citation></ref><ref id="B30-antibiotics-09-00480"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathmasiri</surname><given-names>W.</given-names></name><name><surname>Seedi</surname><given-names>H.R.E.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Janson</surname><given-names>J.C.</given-names></name><name><surname>Huss</surname><given-names>U.</given-names></name><name><surname>Bohlin</surname><given-names>L.</given-names></name></person-group><article-title>Aryl ketones from <italic>Acronychia pedunculata</italic> with cyclooxygenase-2 inhibitory effects</article-title><source>Chem. Biodivers.</source><year>2005</year><volume>2</volume><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200590026</pub-id><pub-id pub-id-type="pmid">17191994</pub-id></element-citation></ref><ref id="B31-antibiotics-09-00480"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Z.Y.</given-names></name><name><surname>Mu</surname><given-names>Q.</given-names></name><name><surname>Shiu</surname><given-names>W.K.</given-names></name><name><surname>Zeng</surname><given-names>Y.H.</given-names></name><name><surname>Gibbons</surname><given-names>S.</given-names></name></person-group><article-title>Polyisoprenylated benzoylphloroglucinol derivatives from <italic>Hypericum sampsonii</italic></article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1779</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.1021/np0704147</pub-id><pub-id pub-id-type="pmid">18038963</pub-id></element-citation></ref><ref id="B32-antibiotics-09-00480"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.J.</given-names></name><name><surname>Tamez</surname><given-names>P.A.</given-names></name><name><surname>Vu</surname><given-names>D.H.</given-names></name><name><surname>Ghee</surname><given-names>T.T.</given-names></name><name><surname>Nguyen</surname><given-names>V.H.</given-names></name><name><surname>Le</surname><given-names>T.X.</given-names></name><name><surname>Le</surname><given-names>M.H.</given-names></name><name><surname>Nguyen</surname><given-names>M.C.</given-names></name><name><surname>Do</surname><given-names>T.T.</given-names></name><name><surname>Soejarto</surname><given-names>D.D.</given-names></name><etal/></person-group><article-title>Antimalarial compounds from Rhaphidophora decursiva</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1021/np010037c</pub-id><?supplied-pmid 11421741?><pub-id pub-id-type="pmid">11421741</pub-id></element-citation></ref><ref id="B33-antibiotics-09-00480"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Blunder</surname><given-names>M.</given-names></name><name><surname>Fakhrudin</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Noha</surname><given-names>S.M.</given-names></name><name><surname>Malainer</surname><given-names>C.</given-names></name><name><surname>Kramer</surname><given-names>M.P.</given-names></name><name><surname>Cocic</surname><given-names>A.</given-names></name><name><surname>Kunert</surname><given-names>O.</given-names></name><name><surname>Schinkovitz</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Polyacetylenes from notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e61755</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061755</pub-id><?supplied-pmid 23630612?><pub-id pub-id-type="pmid">23630612</pub-id></element-citation></ref><ref id="B34-antibiotics-09-00480"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhrudin</surname><given-names>N.</given-names></name><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Cabaravdic</surname><given-names>M.</given-names></name><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Malainer</surname><given-names>C.</given-names></name><name><surname>Schachner</surname><given-names>D.</given-names></name><name><surname>Heiss</surname><given-names>E.H.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Noha</surname><given-names>S.M.</given-names></name><name><surname>Grzywacz</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Identification of plumericin as a potent new inhibitor of the NF-kappaB pathway with anti-inflammatory activity in vitro and in vivo</article-title><source>Br. J. Pharm.</source><year>2014</year><volume>171</volume><fpage>1676</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1111/bph.12558</pub-id><?supplied-pmid 24329519?><pub-id pub-id-type="pmid">24329519</pub-id></element-citation></ref><ref id="B35-antibiotics-09-00480"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabona</surname><given-names>U.</given-names></name><name><surname>Viljoen</surname><given-names>A.</given-names></name><name><surname>Shikanga</surname><given-names>E.</given-names></name><name><surname>Marston</surname><given-names>A.</given-names></name><name><surname>Vuuren</surname><given-names>S.V.</given-names></name></person-group><article-title>Antimicrobial activity of southern African medicinal plants with dermatological relevance: From an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>148</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.03.056</pub-id><pub-id pub-id-type="pmid">23545456</pub-id></element-citation></ref><ref id="B36-antibiotics-09-00480"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nievergelt</surname><given-names>A.</given-names></name><name><surname>Huonker</surname><given-names>P.</given-names></name><name><surname>Schoop</surname><given-names>R.</given-names></name><name><surname>Altmann</surname><given-names>K.H.</given-names></name><name><surname>Gertsch</surname><given-names>J.</given-names></name></person-group><article-title>Identification of serotonin 5-HT1A receptor partial agonists in ginger</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>3345</fpage><lpage>3351</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2010.02.062</pub-id><pub-id pub-id-type="pmid">20363635</pub-id></element-citation></ref><ref id="B37-antibiotics-09-00480"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junio</surname><given-names>H.A.</given-names></name><name><surname>Cordero</surname><given-names>A.A.S.</given-names></name><name><surname>Ettefagh</surname><given-names>K.A.</given-names></name><name><surname>Burns</surname><given-names>J.T.</given-names></name><name><surname>Micko</surname><given-names>K.T.</given-names></name><name><surname>Graf</surname><given-names>T.N.</given-names></name><name><surname>Richter</surname><given-names>S.J.</given-names></name><name><surname>Cannon</surname><given-names>R.E.</given-names></name><name><surname>Oberlies</surname><given-names>N.H.</given-names></name><name><surname>Cech</surname><given-names>N.B.</given-names></name></person-group><article-title>Synergy-directed fractionation of botanical medicines: A case study with goldenseal (<italic>Hydrastis canadensis</italic>)</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1021/np200336g</pub-id><?supplied-pmid 21661731?><pub-id pub-id-type="pmid">21661731</pub-id></element-citation></ref><ref id="B38-antibiotics-09-00480"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndhlala</surname><given-names>A.R.</given-names></name><name><surname>Aderogba</surname><given-names>M.A.</given-names></name><name><surname>Ncube</surname><given-names>B.</given-names></name><name><surname>Staden</surname><given-names>J.V.</given-names></name></person-group><article-title>Anti-oxidative and cholinesterase inhibitory effects of leaf extracts and their isolated compounds from two closely related Croton species</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>1916</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.3390/molecules18021916</pub-id><?supplied-pmid 23377133?><pub-id pub-id-type="pmid">23377133</pub-id></element-citation></ref><ref id="B39-antibiotics-09-00480"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitteranon</surname><given-names>V.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Darien</surname><given-names>B.J.</given-names></name><name><surname>Parkin</surname><given-names>K.</given-names></name></person-group><article-title>Isolation and synergism of in vitro anti-inflammatory and quinone reductase (QR) inducing agents from the fruits of <italic>Morinda citrifolia</italic> (noni)</article-title><source>Food Res. Int.</source><year>2011</year><volume>44</volume><fpage>2271</fpage><lpage>2277</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2010.11.009</pub-id></element-citation></ref><ref id="B40-antibiotics-09-00480"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tafesh</surname><given-names>A.</given-names></name><name><surname>Najami</surname><given-names>N.</given-names></name><name><surname>Jadoun</surname><given-names>J.</given-names></name><name><surname>Halahlih</surname><given-names>F.</given-names></name><name><surname>Riepl</surname><given-names>H.</given-names></name><name><surname>Azaizeh</surname><given-names>H.</given-names></name></person-group><article-title>Synergistic antibacterial effects of polyphenolic compounds from olive mill wastewater</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2011/431021</pub-id></element-citation></ref><ref id="B41-antibiotics-09-00480"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Qu</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Luo</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Investigation of antioxidant interactions between <italic>Radix astragali</italic> and <italic>Cimicifuga foetida</italic> and identification of synergistic antioxidant compounds</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e87221</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087221</pub-id><pub-id pub-id-type="pmid">24498048</pub-id></element-citation></ref><ref id="B42-antibiotics-09-00480"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goretta</surname><given-names>L.A.</given-names></name><name><surname>Leveques</surname><given-names>A.</given-names></name><name><surname>Giuffrida</surname><given-names>F.</given-names></name><name><surname>Michailidis</surname><given-names>F.R.</given-names></name><name><surname>Viton</surname><given-names>F.</given-names></name><name><surname>Barron</surname><given-names>D.</given-names></name><name><surname>Paton</surname><given-names>M.D.</given-names></name><name><surname>Manzano</surname><given-names>S.G.</given-names></name><name><surname>Buelga</surname><given-names>C.S.</given-names></name><name><surname>Williamson</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans</article-title><source>Free. Radic. Biol. Med.</source><year>2012</year><volume>53</volume><fpage>787</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.05.023</pub-id><?supplied-pmid 22664313?><pub-id pub-id-type="pmid">22664313</pub-id></element-citation></ref><ref id="B43-antibiotics-09-00480"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akao</surname><given-names>T.</given-names></name><name><surname>Yoshino</surname><given-names>T.</given-names></name><name><surname>Kobashi</surname><given-names>K.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury</article-title><source>Planta Med.</source><year>2002</year><volume>68</volume><fpage>714</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1055/s-2002-33792</pub-id><?supplied-pmid 12221594?><pub-id pub-id-type="pmid">12221594</pub-id></element-citation></ref><ref id="B44-antibiotics-09-00480"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>C.</given-names></name><name><surname>Berman</surname><given-names>S.</given-names></name><name><surname>Humbert</surname><given-names>O.</given-names></name><name><surname>Lampe</surname><given-names>J.W.</given-names></name></person-group><article-title>In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>596</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1093/jn/134.3.596</pub-id><pub-id pub-id-type="pmid">14988453</pub-id></element-citation></ref><ref id="B45-antibiotics-09-00480"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>OuYang</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The active ingredients of Jiang-Zhi-Ning: Study of the nelumbo nucifera alkaloids and their main bioactive metabolites</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>9855</fpage><lpage>9867</lpage><pub-id pub-id-type="doi">10.3390/molecules17089855</pub-id><pub-id pub-id-type="pmid">22898740</pub-id></element-citation></ref><ref id="B46-antibiotics-09-00480"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>L.</given-names></name><name><surname>Margalef</surname><given-names>M.</given-names></name><name><surname>Pons</surname><given-names>Z.</given-names></name><name><surname>Quinones</surname><given-names>M.</given-names></name><name><surname>Arola</surname><given-names>L.</given-names></name><name><surname>Arnal</surname><given-names>A.A.</given-names></name><name><surname>Muguerza</surname><given-names>B.</given-names></name></person-group><article-title>Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells</article-title><source>J. Nutr. Biochem.</source><year>2013</year><volume>24</volume><fpage>2092</fpage><lpage>2099</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.08.001</pub-id><?supplied-pmid 24231101?><pub-id pub-id-type="pmid">24231101</pub-id></element-citation></ref><ref id="B47-antibiotics-09-00480"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name></person-group><article-title>Systematic screening and characterization of the major bioactive components of poria cocos and their metabolites in rats by LC-ESI-MS(n)</article-title><source>Biomed. Chromatogr.</source><year>2012</year><volume>26</volume><fpage>1109</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1002/bmc.1756</pub-id><pub-id pub-id-type="pmid">22213174</pub-id></element-citation></ref><ref id="B48-antibiotics-09-00480"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>J.Y.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>H.Y.</given-names></name><name><surname>Qi</surname><given-names>L.W.</given-names></name><name><surname>Wang</surname><given-names>C.Z.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Yuan</surname><given-names>C.S.</given-names></name></person-group><article-title>Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry</article-title><source>J. Chromatogr. A</source><year>2013</year><volume>1286</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2013.02.053</pub-id><?supplied-pmid 23499252?><pub-id pub-id-type="pmid">23499252</pub-id></element-citation></ref><ref id="B49-antibiotics-09-00480"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>J.R.</given-names></name><name><surname>Nagarajan</surname><given-names>S.</given-names></name><name><surname>Badger</surname><given-names>T.M.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name></person-group><article-title>Phenolic acids are in vivo atheroprotective compounds appearing in the serum of rats after blueberry consumption</article-title><source>J. Agric. Food Chem.</source><year>2011</year><volume>59</volume><fpage>10381</fpage><lpage>10387</lpage><pub-id pub-id-type="doi">10.1021/jf2025264</pub-id><pub-id pub-id-type="pmid">21866950</pub-id></element-citation></ref><ref id="B50-antibiotics-09-00480"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tawfike</surname><given-names>A.F.</given-names></name><name><surname>Viegelmann</surname><given-names>C.</given-names></name><name><surname>Ebel</surname><given-names>R.E.</given-names></name></person-group><article-title>Metabolomics and dereplication strategies in natural products</article-title><source>Methods Mol. Biol.</source><year>2013</year><volume>1055</volume><fpage>227</fpage><lpage>244</lpage><?supplied-pmid 23963915?><pub-id pub-id-type="pmid">23963915</pub-id></element-citation></ref><ref id="B51-antibiotics-09-00480"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfender</surname><given-names>J.L.</given-names></name><name><surname>Marti</surname><given-names>G.</given-names></name><name><surname>Thomas</surname><given-names>A.</given-names></name><name><surname>Bertrand</surname><given-names>S.</given-names></name></person-group><article-title>Current approaches and challenges for the metabolite profiling of complex natural extracts</article-title><source>J. Chromatogr. A</source><year>2015</year><volume>1382</volume><fpage>136</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2014.10.091</pub-id><pub-id pub-id-type="pmid">25464997</pub-id></element-citation></ref><ref id="B52-antibiotics-09-00480"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;lcemal</surname><given-names>D.</given-names></name><name><surname>Masullo</surname><given-names>M.</given-names></name><name><surname>Napolitano</surname><given-names>A.</given-names></name><name><surname>Karay&#x00131;ld&#x00131;r&#x00131;m</surname><given-names>T.</given-names></name><name><surname>Bedir</surname><given-names>E.</given-names></name><name><surname>&#x000c7;al&#x00131;&#x0015f;kan</surname><given-names>&#x000d6;.A.</given-names></name><name><surname>Piacente</surname><given-names>S.</given-names></name></person-group><article-title>Oleanane glycosides from <italic>Astragalus tauricolus</italic>: Isolation and structural elucidation based on a preliminary liquid chromatography-electrospray ionization tandem mass spectrometry profiling</article-title><source>Phytochemistry</source><year>2013</year><volume>86</volume><fpage>184</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2012.10.001</pub-id><pub-id pub-id-type="pmid">23107778</pub-id></element-citation></ref><ref id="B53-antibiotics-09-00480"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Yang</surname><given-names>N.S.</given-names></name><name><surname>Chen</surname><given-names>Y.P.</given-names></name><name><surname>Lo</surname><given-names>C.P.</given-names></name><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Tien</surname><given-names>Y.J.</given-names></name><name><surname>Tsai</surname><given-names>P.W.</given-names></name><name><surname>Shyur</surname><given-names>L.F.</given-names></name></person-group><article-title>Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of echinacea plants</article-title><source>J. Nutr. Biochem.</source><year>2010</year><volume>21</volume><fpage>1045</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.08.010</pub-id><pub-id pub-id-type="pmid">20005088</pub-id></element-citation></ref><ref id="B54-antibiotics-09-00480"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inui</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pro</surname><given-names>S.M.</given-names></name><name><surname>Franzblau</surname><given-names>S.G.</given-names></name><name><surname>Pauli</surname><given-names>G.F.</given-names></name></person-group><article-title>Unbiased evaluation of bioactive secondary metabolites in complex matrices</article-title><source>Fitoterapia</source><year>2012</year><volume>83</volume><fpage>1218</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.06.012</pub-id><pub-id pub-id-type="pmid">22766306</pub-id></element-citation></ref><ref id="B55-antibiotics-09-00480"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keerthi</surname><given-names>D.</given-names></name><name><surname>Geethu</surname><given-names>C.</given-names></name><name><surname>Nair</surname><given-names>R.A.</given-names></name><name><surname>Pillai</surname><given-names>P.</given-names></name></person-group><article-title>Metabolic profiling of zingiber zerumbet following pythium myriotylum infection: Investigations on the defensive role of the principal secondary metabolite, zerumbone</article-title><source>Appl. Biochem. Biotechnol.</source><year>2014</year><volume>172</volume><fpage>2593</fpage><lpage>2603</lpage><pub-id pub-id-type="doi">10.1007/s12010-013-0707-z</pub-id><pub-id pub-id-type="pmid">24414941</pub-id></element-citation></ref><ref id="B56-antibiotics-09-00480"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Cui</surname><given-names>X.M.</given-names></name><name><surname>Li</surname><given-names>J.J.</given-names></name><name><surname>Qi</surname><given-names>Y.T.</given-names></name><name><surname>Zhang</surname><given-names>P.H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group><article-title>Target separation of a new anti-tumor saponin and metabolic profiling of leaves of panax notoginseng by liquid chromatography with eletrospray ionization quadrupole time-of-flight mass spectrometry</article-title><source>J. Pharm. Biomed. Anal.</source><year>2012</year><volume>59</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2011.10.004</pub-id><pub-id pub-id-type="pmid">22047761</pub-id></element-citation></ref><ref id="B57-antibiotics-09-00480"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modarai</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Suter</surname><given-names>A.</given-names></name><name><surname>Kortenkamp</surname><given-names>A.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Metabolomic profiling of liquid echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4)</article-title><source>Planta Med.</source><year>2010</year><volume>76</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1186152</pub-id><pub-id pub-id-type="pmid">19790031</pub-id></element-citation></ref><ref id="B58-antibiotics-09-00480"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandasi</surname><given-names>M.</given-names></name><name><surname>Kamatou</surname><given-names>G.P.</given-names></name><name><surname>Viljoen</surname><given-names>A.M.</given-names></name></person-group><article-title>An untargeted metabolomic approach in the chemotaxonomic assessment of two salvia species as a potential source of alpha-bisabolol</article-title><source>Phytochemistry</source><year>2012</year><volume>84</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2012.08.009</pub-id><pub-id pub-id-type="pmid">22981002</pub-id></element-citation></ref><ref id="B59-antibiotics-09-00480"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyllenhaal</surname><given-names>C.</given-names></name><name><surname>Kadushin</surname><given-names>M.R.</given-names></name><name><surname>Southavong</surname><given-names>B.</given-names></name><name><surname>Sydara</surname><given-names>K.</given-names></name><name><surname>Bouamanivong</surname><given-names>S.</given-names></name><name><surname>Xaiveu</surname><given-names>M.</given-names></name><name><surname>Xuan</surname><given-names>L.T.</given-names></name><name><surname>Hiep</surname><given-names>N.T.</given-names></name><name><surname>Hung</surname><given-names>N.V.</given-names></name><name><surname>Loc</surname><given-names>P.K.</given-names></name><etal/></person-group><article-title>Ethnobotanical approach versus random approach in the search for new bioactive compounds: Support of a hypothesis</article-title><source>Pharm. Biol.</source><year>2012</year><volume>50</volume><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.3109/13880209.2011.634424</pub-id><pub-id pub-id-type="pmid">22196581</pub-id></element-citation></ref><ref id="B60-antibiotics-09-00480"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khafagi</surname><given-names>I.K.</given-names></name><name><surname>Dewedar</surname><given-names>A.</given-names></name></person-group><article-title>The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>71</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00164-1</pub-id><pub-id pub-id-type="pmid">10940572</pub-id></element-citation></ref><ref id="B61-antibiotics-09-00480"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>A.L.</given-names></name><name><surname>Kristensen</surname><given-names>L.H.</given-names></name><name><surname>Stephansen</surname><given-names>K.B.</given-names></name><name><surname>Kristensen</surname><given-names>J.B.</given-names></name><name><surname>Helgstrand</surname><given-names>C.</given-names></name><name><surname>Lees</surname><given-names>M.</given-names></name><name><surname>Cloos</surname><given-names>P.</given-names></name><name><surname>Helin</surname><given-names>K.</given-names></name><name><surname>Gajhede</surname><given-names>M.</given-names></name><name><surname>Olsen</surname><given-names>L.</given-names></name></person-group><article-title>Identification of catechols as histone-lysine demethylase inhibitors</article-title><source>FEBS Lett.</source><year>2012</year><volume>586</volume><fpage>1190</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.03.001</pub-id><pub-id pub-id-type="pmid">22575654</pub-id></element-citation></ref><ref id="B62-antibiotics-09-00480"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>D.R.</given-names></name><name><surname>Leit&#x000e3;o</surname><given-names>G.G.</given-names></name><name><surname>Coelho</surname><given-names>T.S.</given-names></name><name><surname>Silva</surname><given-names>P.E.A.</given-names></name><name><surname>Louren&#x000e7;o</surname><given-names>M.C.S.</given-names></name><name><surname>Leit&#x000e3;o</surname><given-names>S.G.</given-names></name></person-group><article-title>Ethnopharmacological versus random plant selection methods for the evaluation of the antimycobacterial activity</article-title><source>Rev. Bras. Farm.</source><year>2011</year><volume>21</volume><fpage>793</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2011005000084</pub-id></element-citation></ref><ref id="B63-antibiotics-09-00480"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaneyfelt</surname><given-names>M.E.</given-names></name><name><surname>Burke</surname><given-names>A.D.</given-names></name><name><surname>Graff</surname><given-names>J.W.</given-names></name><name><surname>Jutila</surname><given-names>M.A.</given-names></name><name><surname>Hardy</surname><given-names>M.E.</given-names></name></person-group><article-title>Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay</article-title><source>Virol. J.</source><year>2006</year><volume>3</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-3-68</pub-id><?supplied-pmid 16948846?><pub-id pub-id-type="pmid">16948846</pub-id></element-citation></ref><ref id="B64-antibiotics-09-00480"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Wenzig</surname><given-names>E.M.P.</given-names></name><name><surname>Linder</surname><given-names>T.</given-names></name><name><surname>Wawrosch</surname><given-names>C.</given-names></name><name><surname>Uhrin</surname><given-names>P.</given-names></name><name><surname>Temml</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Schwaiger</surname><given-names>S.</given-names></name><name><surname>Heiss</surname><given-names>E.H.</given-names></name><etal/></person-group><article-title>Discovery and resupply of pharmacologically active plant-derived natural products: A review</article-title><source>Biotechnol. Adv.</source><year>2015</year><volume>33</volume><fpage>1582</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2015.08.001</pub-id><?supplied-pmid 26281720?><pub-id pub-id-type="pmid">26281720</pub-id></element-citation></ref><ref id="B65-antibiotics-09-00480"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekuadzi</surname><given-names>E.</given-names></name><name><surname>Dickson</surname><given-names>R.</given-names></name><name><surname>Fleischer</surname><given-names>T.</given-names></name><name><surname>Annan</surname><given-names>K.</given-names></name><name><surname>Pistorius</surname><given-names>D.</given-names></name><name><surname>Oberer</surname><given-names>L.</given-names></name><name><surname>Gibbons</surname><given-names>S.</given-names></name></person-group><article-title>Flavonoid glycosides from the stem bark of margaritaria discoidea demonstrate antibacterial and free radical scavenging activities</article-title><source>Phytother. Res.</source><year>2014</year><volume>28</volume><fpage>784</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1002/ptr.5053</pub-id><pub-id pub-id-type="pmid">23970448</pub-id></element-citation></ref><ref id="B66-antibiotics-09-00480"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noreen</surname><given-names>Y.</given-names></name><name><surname>Seedi</surname><given-names>H.E.</given-names></name><name><surname>Perera</surname><given-names>P.</given-names></name><name><surname>Bohlin</surname><given-names>L.</given-names></name></person-group><article-title>Two new isoflavones from ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis</article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1021/np970198+</pub-id><pub-id pub-id-type="pmid">9461647</pub-id></element-citation></ref><ref id="B67-antibiotics-09-00480"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siriwatanametanon</surname><given-names>N.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>The Thai medicinal plant gynura pseudochina var. hispida: Chemical composition and in vitro NF-kappaB inhibitory activity</article-title><source>Nat. Prod. Commun.</source><year>2011</year><volume>6</volume><fpage>627</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1177/1934578X1100600512</pub-id><pub-id pub-id-type="pmid">21615022</pub-id></element-citation></ref><ref id="B68-antibiotics-09-00480"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabricant</surname><given-names>D.S.</given-names></name><name><surname>Farnsworth</surname><given-names>N.R.</given-names></name></person-group><article-title>The value of plants used in traditional medicine for drug discovery</article-title><source>Environ. Health Perspect.</source><year>2001</year><volume>109</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">11250806</pub-id></element-citation></ref><ref id="B69-antibiotics-09-00480"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Ethnopharmacology in the 21st century&#x02014;Grand challenges</article-title><source>Front. Pharm.</source><year>2010</year><volume>1</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.3389/fphar.2010.00008</pub-id></element-citation></ref><ref id="B70-antibiotics-09-00480"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonti</surname><given-names>M.</given-names></name></person-group><article-title>The future is written: Impact of scripts on the cognition, selection, knowledge and transmission of medicinal plant use and its implications for ethnobotany and ethnopharmacology</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>134</volume><fpage>542</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.01.017</pub-id><pub-id pub-id-type="pmid">21255636</pub-id></element-citation></ref><ref id="B71-antibiotics-09-00480"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahamad</surname><given-names>S.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>F.I.</given-names></name><name><surname>Dwivedi</surname><given-names>N.</given-names></name><name><surname>Ali</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Imtaiyaz Hassan</surname><given-names>M.</given-names></name></person-group><article-title>QSAR based therapeutic management of <italic>M. tuberculosis</italic></article-title><source>Arch. Pharm. Res.</source><year>2017</year><volume>40</volume><fpage>676</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1007/s12272-017-0914-1</pub-id><pub-id pub-id-type="pmid">28456911</pub-id></element-citation></ref><ref id="B72-antibiotics-09-00480"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavernet</surname><given-names>L.</given-names></name><name><surname>Talevi</surname><given-names>A.</given-names></name><name><surname>Castro</surname><given-names>E.A.</given-names></name><name><surname>Blanch</surname><given-names>L.E.B.</given-names></name></person-group><article-title>A Combined virtual screening 2D and 3D QSAR methodology for the selection of new anticonvulsant candidates from a natural product library</article-title><source>QSAR Comb. Sci.</source><year>2008</year><volume>27</volume><fpage>1120</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1002/qsar.200730055</pub-id></element-citation></ref><ref id="B73-antibiotics-09-00480"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaulton</surname><given-names>A.</given-names></name><name><surname>Bellis</surname><given-names>L.J.</given-names></name><name><surname>Bento</surname><given-names>A.P.</given-names></name><name><surname>Chambers</surname><given-names>J.</given-names></name><name><surname>Davies</surname><given-names>M.</given-names></name><name><surname>Hersey</surname><given-names>A.</given-names></name><name><surname>Light</surname><given-names>Y.</given-names></name><name><surname>McGlinchey</surname><given-names>S.</given-names></name><name><surname>Michalovich</surname><given-names>D.</given-names></name><name><surname>Lazikani</surname><given-names>B.A.</given-names></name><etal/></person-group><article-title>ChEMBL: A large-scale bioactivity database for drug discovery</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>40</volume><pub-id pub-id-type="doi">10.1093/nar/gkr777</pub-id><?supplied-pmid 21948594?><pub-id pub-id-type="pmid">21948594</pub-id></element-citation></ref><ref id="B74-antibiotics-09-00480"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Cheng</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Bryant</surname><given-names>S.H.</given-names></name></person-group><article-title>PubChem as a public resource for drug discovery</article-title><source>Drug Discov. Today</source><year>2010</year><volume>15</volume><fpage>1052</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2010.10.003</pub-id><?supplied-pmid 20970519?><pub-id pub-id-type="pmid">20970519</pub-id></element-citation></ref><ref id="B75-antibiotics-09-00480"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhrudin</surname><given-names>N.</given-names></name><name><surname>Ladurner</surname><given-names>A.</given-names></name><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Heiss</surname><given-names>E.H.</given-names></name><name><surname>Baumgartner</surname><given-names>L.</given-names></name><name><surname>Markt</surname><given-names>P.</given-names></name><name><surname>Schuster</surname><given-names>D.</given-names></name><name><surname>Ellmerer</surname><given-names>E.P.</given-names></name><name><surname>Wolber</surname><given-names>G.</given-names></name><name><surname>Rollinger</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma</article-title><source>Mol. Pharm.</source><year>2010</year><volume>77</volume><fpage>559</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1124/mol.109.062141</pub-id></element-citation></ref><ref id="B76-antibiotics-09-00480"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name></person-group><article-title>Molecular determinants of magnolol targeting both RXRalpha and PPARgamma</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e28253</elocation-id><pub-id pub-id-type="pmid">22140563</pub-id></element-citation></ref><ref id="B77-antibiotics-09-00480"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waszkowycz</surname><given-names>B.</given-names></name><name><surname>Clark</surname><given-names>D.E.</given-names></name><name><surname>Gancia</surname><given-names>E.</given-names></name></person-group><article-title>Outstanding challenges in protein&#x02013;ligand docking and structure-based virtual screening</article-title><source>Wiley Interdiscip. Rev. Comput. Mol. Sci.</source><year>2011</year><volume>1</volume><fpage>229</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1002/wcms.18</pub-id></element-citation></ref><ref id="B78-antibiotics-09-00480"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balamurugan</surname><given-names>K.</given-names></name><name><surname>Nishanthini</surname><given-names>A.</given-names></name><name><surname>Mohan</surname><given-names>V.R.</given-names></name></person-group><article-title>GC&#x02013;MS analysis of <italic>Polycarpaea corymbosa</italic> (L.) lam whole plant</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2012</year><volume>2</volume><fpage>S1289</fpage><lpage>S1292</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60402-X</pub-id></element-citation></ref><ref id="B79-antibiotics-09-00480"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doshi</surname><given-names>G.M.</given-names></name><name><surname>Nalawade</surname><given-names>V.V.</given-names></name><name><surname>Mukadam</surname><given-names>A.S.</given-names></name><name><surname>Chaskar</surname><given-names>P.K.</given-names></name><name><surname>Zine</surname><given-names>S.P.</given-names></name><name><surname>Somani</surname><given-names>R.R.</given-names></name><name><surname>Une</surname><given-names>H.D.</given-names></name></person-group><article-title>Structural elucidation of chemical constituents from <italic>Benincasa hispida</italic> seeds and carissa congesta roots by gas chromatography: Mass spectroscopy</article-title><source>Pharmacogn. Res.</source><year>2015</year><volume>7</volume><fpage>282</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.4103/0974-8490.157179</pub-id></element-citation></ref><ref id="B80-antibiotics-09-00480"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>D.</given-names></name><name><surname>Patnaik</surname><given-names>R.</given-names></name><name><surname>Ghosh</surname><given-names>G.</given-names></name><name><surname>Padhy</surname><given-names>R.N.</given-names></name></person-group><article-title>In vitro antibacterial activity, gas chromatography-mass spectrometry analysis of <italic>Woodfordia fruticosa</italic> kurz. leaf extract and host toxicity testing with in vitro cultured lymphocytes from human umbilical cord blood</article-title><source>Osong Public Health Res. Perspect.</source><year>2014</year><volume>5</volume><fpage>298</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.phrp.2014.08.001</pub-id><pub-id pub-id-type="pmid">25389517</pub-id></element-citation></ref><ref id="B81-antibiotics-09-00480"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mickymaray</surname><given-names>S.</given-names></name><name><surname>Aboody</surname><given-names>M.S.A.</given-names></name><name><surname>Rath</surname><given-names>P.K.</given-names></name><name><surname>Annamalai</surname><given-names>P.</given-names></name><name><surname>Nooruddin</surname><given-names>T.</given-names></name></person-group><article-title>Screening and antibacterial efficacy of selected Indian medicinal plants</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2016</year><volume>6</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2015.12.005</pub-id></element-citation></ref><ref id="B82-antibiotics-09-00480"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname><given-names>S.</given-names></name><name><surname>Piccioni</surname><given-names>M.</given-names></name><name><surname>Felicetti</surname><given-names>T.</given-names></name><name><surname>De Marco</surname><given-names>S.</given-names></name><name><surname>Manfroni</surname><given-names>G.</given-names></name><name><surname>Pagiotti</surname><given-names>R.</given-names></name><name><surname>Nocchetti</surname><given-names>M.</given-names></name><name><surname>Cecchetti</surname><given-names>V.</given-names></name><name><surname>Pietrella</surname><given-names>D.</given-names></name></person-group><article-title>Investigation on the effect of known potent <italic>S. aureus</italic> NorA efflux pump inhibitors on the staphylococcal biofilm formation</article-title><source>RSC Adv.</source><year>2017</year><volume>7</volume><fpage>37007</fpage><lpage>37014</lpage><pub-id pub-id-type="doi">10.1039/C7RA03859C</pub-id></element-citation></ref><ref id="B83-antibiotics-09-00480"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>M.P.</given-names></name><name><surname>Rath</surname><given-names>S.</given-names></name><name><surname>Swain</surname><given-names>S.S.</given-names></name><name><surname>Ghosh</surname><given-names>G.</given-names></name><name><surname>Das</surname><given-names>D.</given-names></name><name><surname>Padhy</surname><given-names>R.N.</given-names></name></person-group><article-title>In vitro antibacterial activity of crude extracts of 9 selected medicinal plants against UTI causing MDR bacteria</article-title><source>J. King Saud Univ. Sci.</source><year>2017</year><volume>29</volume><fpage>84</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jksus.2015.05.007</pub-id></element-citation></ref><ref id="B84-antibiotics-09-00480"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesa</surname><given-names>S.</given-names></name><name><surname>Sisto</surname><given-names>F.</given-names></name><name><surname>Zengin</surname><given-names>G.</given-names></name><name><surname>Scaccabarozzi</surname><given-names>D.</given-names></name><name><surname>Kokolakis</surname><given-names>A.K.</given-names></name><name><surname>Scaltrito</surname><given-names>M.M.</given-names></name><name><surname>Grande</surname><given-names>R.</given-names></name><name><surname>Locatelli</surname><given-names>M.</given-names></name><name><surname>Cacciagrano</surname><given-names>F.</given-names></name><name><surname>Angiolella</surname><given-names>L.</given-names></name></person-group><article-title>Phytochemical analyses and pharmacological screening of neem oil</article-title><source>S. Afr. J. Bot.</source><year>2019</year><volume>120</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2018.10.019</pub-id></element-citation></ref><ref id="B85-antibiotics-09-00480"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semeniuc</surname><given-names>C.A.</given-names></name><name><surname>Pop</surname><given-names>C.R.</given-names></name><name><surname>Rotar</surname><given-names>A.M.</given-names></name></person-group><article-title>Antibacterial activity and interactions of plant essential oil combinations against gram-positive and gram-negative bacteria</article-title><source>J. Food Drug Anal.</source><year>2017</year><volume>25</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.jfda.2016.06.002</pub-id><?supplied-pmid 28911683?><pub-id pub-id-type="pmid">28911683</pub-id></element-citation></ref><ref id="B86-antibiotics-09-00480"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>G.</given-names></name><name><surname>Menghini</surname><given-names>L.</given-names></name><name><surname>Di Sotto</surname><given-names>A.</given-names></name><name><surname>Mancinelli</surname><given-names>R.</given-names></name><name><surname>Sisto</surname><given-names>F.</given-names></name><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Cesa</surname><given-names>S.</given-names></name><name><surname>Fraschetti</surname><given-names>C.</given-names></name><name><surname>Filippi</surname><given-names>A.</given-names></name><name><surname>Angiolella</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Chromatographic Analyses, in vitro biological activities, and cytotoxicity of cannabis sativa L. essential oil: A multidisciplinary study</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>3266</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23123266</pub-id></element-citation></ref><ref id="B87-antibiotics-09-00480"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>G.</given-names></name><name><surname>Turner</surname><given-names>T.</given-names></name><name><surname>Nelson</surname><given-names>E.</given-names></name><name><surname>Sparks</surname><given-names>L.</given-names></name><name><surname>Langland</surname><given-names>J.</given-names></name></person-group><article-title>Bacterial development of resistance to botanical antimicrobials</article-title><source>J. Evol. Health</source><year>2017</year><volume>2</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.15310/2334-3591.1065</pub-id></element-citation></ref><ref id="B88-antibiotics-09-00480"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.K.</given-names></name><name><surname>Pahwa</surname><given-names>S.</given-names></name><name><surname>Nandanwar</surname><given-names>H.</given-names></name><name><surname>Jachak</surname><given-names>S.M.</given-names></name></person-group><article-title>Phenylpropanoids of <italic>Alpinia galanga</italic> as efflux pump inhibitors in mycobacterium smegmatis mc(2) 155</article-title><source>Fitoterapia</source><year>2012</year><volume>83</volume><fpage>1248</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.06.008</pub-id><pub-id pub-id-type="pmid">22735598</pub-id></element-citation></ref><ref id="B89-antibiotics-09-00480"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>G.R.</given-names></name><name><surname>Upadhyay</surname><given-names>H.C.</given-names></name><name><surname>Yadav</surname><given-names>D.K.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Srivastava</surname><given-names>S.K.</given-names></name><name><surname>Khan</surname><given-names>F.</given-names></name><name><surname>Darmwal</surname><given-names>N.S.</given-names></name><name><surname>Darokar</surname><given-names>M.P.</given-names></name></person-group><article-title>4-Hydroxy-alpha-tetralone and its derivative as drug resistance reversal agents in multi drug resistant <italic>Escherichia coli</italic></article-title><source>Chem. Biol. Drug Des.</source><year>2014</year><volume>83</volume><fpage>482</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1111/cbdd.12263</pub-id><pub-id pub-id-type="pmid">24267788</pub-id></element-citation></ref><ref id="B90-antibiotics-09-00480"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghayan</surname><given-names>S.S.</given-names></name><name><surname>Mogadam</surname><given-names>H.K.</given-names></name><name><surname>Fazli</surname><given-names>M.</given-names></name><name><surname>Sarokhalil</surname><given-names>D.D.</given-names></name><name><surname>Khoramrooz</surname><given-names>S.S.</given-names></name><name><surname>Jabalameli</surname><given-names>F.</given-names></name><name><surname>Yaslianifard</surname><given-names>S.</given-names></name><name><surname>Mirzaii</surname><given-names>M.</given-names></name></person-group><article-title>The effects of berberine and palmatine on efflux pumps inhibition with different gene patterns in <italic>Pseudomonas aeruginosa</italic> isolated from burn infections</article-title><source>Avicenna J. Med. Biotechnol.</source><year>2017</year><volume>9</volume><fpage>2</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">28090273</pub-id></element-citation></ref><ref id="B91-antibiotics-09-00480"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maisuria</surname><given-names>V.B.</given-names></name><name><surname>Hosseinidoust</surname><given-names>Z.</given-names></name><name><surname>Tufenkji</surname><given-names>N.</given-names></name></person-group><article-title>Polyphenolic extract from maple syrup potentiates antibiotic susceptibility and reduces biofilm formation of <italic>Pathogenic bacteria</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2015</year><volume>81</volume><fpage>3782</fpage><lpage>3792</lpage><pub-id pub-id-type="doi">10.1128/AEM.00239-15</pub-id><pub-id pub-id-type="pmid">25819960</pub-id></element-citation></ref><ref id="B92-antibiotics-09-00480"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>G.R.</given-names></name><name><surname>Tyagi</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Tripathi</surname><given-names>S.</given-names></name><name><surname>Pati</surname><given-names>S.</given-names></name><name><surname>Srivastava</surname><given-names>S.K.</given-names></name><name><surname>Darokar</surname><given-names>M.P.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name></person-group><article-title>Antibiotics potentiating potential of catharanthine against superbug <italic>Pseudomonas aeruginosa</italic></article-title><source>J. Biomol. Struct. Dyn.</source><year>2018</year><volume>36</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1080/07391102.2017.1413424</pub-id><?supplied-pmid 29210342?><pub-id pub-id-type="pmid">28024437</pub-id></element-citation></ref><ref id="B93-antibiotics-09-00480"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siriyong</surname><given-names>T.</given-names></name><name><surname>Srimanote</surname><given-names>P.</given-names></name><name><surname>Chusri</surname><given-names>S.</given-names></name><name><surname>Yingyongnarongkul</surname><given-names>B.E.</given-names></name><name><surname>Suaisom</surname><given-names>C.</given-names></name><name><surname>Tipmanee</surname><given-names>V.</given-names></name><name><surname>Voravuthikunchai</surname><given-names>S.P.</given-names></name></person-group><article-title>Conessine as a novel inhibitor of multidrug efflux pump systems in <italic>Pseudomonas aeruginosa</italic></article-title><source>BMC Complement. Altern. Med.</source><year>2017</year><volume>17</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/s12906-017-1913-y</pub-id><?supplied-pmid 28806947?><pub-id pub-id-type="pmid">28049463</pub-id></element-citation></ref><ref id="B94-antibiotics-09-00480"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakarla</surname><given-names>P.</given-names></name><name><surname>Floyd</surname><given-names>J.</given-names></name><name><surname>Mukherjee</surname><given-names>M.</given-names></name><name><surname>Devireddy</surname><given-names>A.R.</given-names></name><name><surname>Inupakutika</surname><given-names>M.A.</given-names></name><name><surname>Ranweera</surname><given-names>I.</given-names></name><name><surname>Kc</surname><given-names>R.</given-names></name><name><surname>Shrestha</surname><given-names>U.</given-names></name><name><surname>Cheeti</surname><given-names>U.R.</given-names></name><name><surname>Willmon</surname><given-names>T.M.</given-names></name><etal/></person-group><article-title>Inhibition of the multidrug efflux pump LmrS from <italic>Staphylococcus aureus</italic> by cumin spice <italic>Cuminum cyminum</italic></article-title><source>Arch. Microbiol.</source><year>2017</year><volume>199</volume><fpage>465</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1007/s00203-016-1314-5</pub-id><?supplied-pmid 27830269?><pub-id pub-id-type="pmid">27830269</pub-id></element-citation></ref><ref id="B95-antibiotics-09-00480"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chovanova</surname><given-names>R.</given-names></name><name><surname>Mezovska</surname><given-names>J.</given-names></name><name><surname>Vaverkova</surname><given-names>S.</given-names></name><name><surname>Mikulasova</surname><given-names>M.</given-names></name></person-group><article-title>The inhibition the Tet(K) efflux pump of tetracycline resistant <italic>Staphylococcus epidermidis</italic> by essential oils from three salvia species</article-title><source>Lett. Appl. Microbiol.</source><year>2015</year><volume>61</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/lam.12424</pub-id><pub-id pub-id-type="pmid">25846244</pub-id></element-citation></ref><ref id="B96-antibiotics-09-00480"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limaverde</surname><given-names>P.W.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>Cunha</surname><given-names>F.A.B.D.</given-names></name><name><surname>Crispim</surname><given-names>F.D.</given-names></name><name><surname>Figueredo</surname><given-names>F.G.</given-names></name><name><surname>Lima</surname><given-names>L.F.</given-names></name><name><surname>Datiane</surname><given-names>M.O.-T.C.</given-names></name><name><surname>Matos</surname><given-names>Y.D.</given-names></name><name><surname>Braga</surname><given-names>M.F.B.M.</given-names></name><name><surname>Menezes</surname><given-names>I.R.A.</given-names></name><etal/></person-group><article-title>Inhibition of the TetK efflux-pump by the essential oil of chenopodium ambrosioides L. and alpha-terpinene against <italic>Staphylococcus aureus</italic> IS-58</article-title><source>Food Chem. Toxicol.</source><year>2017</year><volume>109</volume><fpage>957</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2017.02.031</pub-id><pub-id pub-id-type="pmid">28238773</pub-id></element-citation></ref><ref id="B97-antibiotics-09-00480"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bag</surname><given-names>A.</given-names></name><name><surname>Chattopadhyay</surname><given-names>R.R.</given-names></name></person-group><article-title>Efflux-pump inhibitory activity of a gallotannin from terminalia chebula fruit against multidrug-resistant uropathogenic <italic>Escherichia coli</italic></article-title><source>Nat. Prod. Res.</source><year>2014</year><volume>28</volume><fpage>1280</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.895729</pub-id><pub-id pub-id-type="pmid">24620744</pub-id></element-citation></ref><ref id="B98-antibiotics-09-00480"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holler</surname><given-names>J.G.</given-names></name><name><surname>Christensen</surname><given-names>S.B.</given-names></name><name><surname>Slotved</surname><given-names>H.C.</given-names></name><name><surname>Rasmussen</surname><given-names>H.B.</given-names></name><name><surname>Guzman</surname><given-names>A.</given-names></name><name><surname>Olsen</surname><given-names>C.E.</given-names></name><name><surname>Petersen</surname><given-names>B.</given-names></name><name><surname>Molgaard</surname><given-names>P.</given-names></name></person-group><article-title>Novel inhibitory activity of the <italic>Staphylococcus aureus</italic> NorA efflux pump by a kaempferol rhamnoside isolated from persea lingue nees</article-title><source>J. Antimicrob. Chemother.</source><year>2012</year><volume>67</volume><fpage>1138</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1093/jac/dks005</pub-id><pub-id pub-id-type="pmid">22311936</pub-id></element-citation></ref><ref id="B99-antibiotics-09-00480"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurya</surname><given-names>A.</given-names></name><name><surname>Dwivedi</surname><given-names>G.R.</given-names></name><name><surname>Darokar</surname><given-names>M.P.</given-names></name><name><surname>Srivastava</surname><given-names>S.K.</given-names></name></person-group><article-title>Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant <italic>Escherichia coli</italic></article-title><source>Chem. Biol. Drug Des.</source><year>2013</year><volume>81</volume><fpage>484</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1111/cbdd.12103</pub-id><pub-id pub-id-type="pmid">23290001</pub-id></element-citation></ref><ref id="B100-antibiotics-09-00480"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiu</surname><given-names>W.K.</given-names></name><name><surname>Malkinson</surname><given-names>J.P.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Curry</surname><given-names>J.</given-names></name><name><surname>Stapleton</surname><given-names>P.</given-names></name><name><surname>Gunaratnam</surname><given-names>M.</given-names></name><name><surname>Neidle</surname><given-names>S.</given-names></name><name><surname>Mushtaq</surname><given-names>S.</given-names></name><name><surname>Warner</surname><given-names>M.</given-names></name><name><surname>Livermore</surname><given-names>D.M.</given-names></name><etal/></person-group><article-title>A new plant-derived antibacterial is an inhibitor of efflux pumps in <italic>Staphylococcus aureus</italic></article-title><source>Int. J. Antimicrob. Agents</source><year>2013</year><volume>42</volume><fpage>513</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2013.08.007</pub-id><pub-id pub-id-type="pmid">24119569</pub-id></element-citation></ref><ref id="B101-antibiotics-09-00480"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bame</surname><given-names>J.R.</given-names></name><name><surname>Graf</surname><given-names>T.N.</given-names></name><name><surname>Junio</surname><given-names>H.A.</given-names></name><name><surname>Bussey</surname><given-names>R.O.</given-names></name><name><surname>Jarmusch</surname><given-names>S.A.</given-names></name><name><surname>Elimat</surname><given-names>T.E.</given-names></name><name><surname>Falkinham</surname><given-names>J.O.</given-names></name><name><surname>Oberlies</surname><given-names>N.H.</given-names></name><name><surname>Cech</surname><given-names>R.A.</given-names></name><name><surname>Cech</surname><given-names>N.B.</given-names></name></person-group><article-title>Sarothrin from <italic>Alkanna orientalis</italic> is an antimicrobial agent and efflux pump inhibitor</article-title><source>Planta Med.</source><year>2013</year><volume>79</volume><fpage>327</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1328259</pub-id><pub-id pub-id-type="pmid">23468310</pub-id></element-citation></ref><ref id="B102-antibiotics-09-00480"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mocan</surname><given-names>A.</given-names></name><name><surname>Babota</surname><given-names>M.</given-names></name><name><surname>Pop</surname><given-names>A.</given-names></name><name><surname>Fizesan</surname><given-names>I.</given-names></name><name><surname>Diuzheva</surname><given-names>A.</given-names></name><name><surname>Locatelli</surname><given-names>M.</given-names></name><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Campestre</surname><given-names>C.</given-names></name><name><surname>Menghini</surname><given-names>L.</given-names></name><name><surname>Sisea</surname><given-names>C.R.</given-names></name><etal/></person-group><article-title>Chemical constituents and biologic activities of sage species: A comparison between <italic>Salvia officinalis</italic> L., <italic>S. glutinosa</italic> L. and <italic>S. transsylvanica</italic> (Schur ex Griseb. &#x00026; Schenk) schur</article-title><source>Antioxidants</source><year>2020</year><volume>9</volume><elocation-id>480</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9060480</pub-id></element-citation></ref><ref id="B103-antibiotics-09-00480"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>B.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name></person-group><article-title>Ex vivo and in situ approaches used to study intestinal absorption</article-title><source>J. Pharm. Toxicol. Methods</source><year>2013</year><volume>68</volume><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.vascn.2013.06.001</pub-id><?supplied-pmid 23831587?><pub-id pub-id-type="pmid">23831587</pub-id></element-citation></ref><ref id="B104-antibiotics-09-00480"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teicher</surname><given-names>B.A.</given-names></name></person-group><article-title>In vivo/ex vivo and in situ assays used in cancer research: A brief review</article-title><source>Toxicol. Pathol.</source><year>2009</year><volume>37</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1177/0192623308329473</pub-id><?supplied-pmid 19098118?><pub-id pub-id-type="pmid">19098118</pub-id></element-citation></ref><ref id="B105-antibiotics-09-00480"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>J.R.</given-names></name><name><surname>Lund</surname><given-names>G.</given-names></name><name><surname>Sapelnikova</surname><given-names>S.</given-names></name><name><surname>Tyrrell</surname><given-names>D.L.</given-names></name><name><surname>Kneteman</surname><given-names>N.M.</given-names></name></person-group><article-title>Chimeric rodents with humanized liver: Bridging the preclinical/clinical trial gap in ADME/toxicity studies</article-title><source>Xenobiotica</source><year>2014</year><volume>44</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.3109/00498254.2013.867553</pub-id><?supplied-pmid 24320885?><pub-id pub-id-type="pmid">24320885</pub-id></element-citation></ref><ref id="B106-antibiotics-09-00480"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zambrowicz</surname><given-names>B.P.</given-names></name><name><surname>Sands</surname><given-names>A.T.</given-names></name></person-group><article-title>Knockouts model the 100 best-selling drugs--will they model the next 100?</article-title><source>Nat. Rev. Drug Discov.</source><year>2003</year><volume>2</volume><fpage>38</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/nrd987</pub-id><pub-id pub-id-type="pmid">12509758</pub-id></element-citation></ref><ref id="B107-antibiotics-09-00480"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name></person-group><article-title>Preclinical experimental models of drug metabolism and disposition in drug discovery and development</article-title><source>Acta Pharm. Sin. B</source><year>2012</year><volume>2</volume><fpage>549</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2012.10.004</pub-id></element-citation></ref><ref id="B108-antibiotics-09-00480"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulak</surname><given-names>R.</given-names></name></person-group><article-title>Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system</article-title><source>Methods Mol. Biol.</source><year>2006</year><volume>351</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">16988441</pub-id></element-citation></ref><ref id="B109-antibiotics-09-00480"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Reilly</surname><given-names>L.P.</given-names></name><name><surname>Luke</surname><given-names>C.J.</given-names></name><name><surname>Perlmutter</surname><given-names>D.H.</given-names></name><name><surname>Silverman</surname><given-names>G.A.</given-names></name><name><surname>Pak</surname><given-names>S.C.C.</given-names></name></person-group><article-title>elegans in high-throughput drug discovery</article-title><source>Adv. Drug Deliv. Rev.</source><year>2014</year><volume>69&#x02013;70</volume><fpage>247</fpage><lpage>253</lpage></element-citation></ref><ref id="B110-antibiotics-09-00480"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>A.J.</given-names></name><name><surname>Lo</surname><given-names>T.W.</given-names></name><name><surname>Zeitler</surname><given-names>B.</given-names></name><name><surname>Pickle</surname><given-names>C.S.</given-names></name><name><surname>Ralston</surname><given-names>E.J.</given-names></name><name><surname>Lee</surname><given-names>A.H.</given-names></name><name><surname>Amora</surname><given-names>R.</given-names></name><name><surname>Miller</surname><given-names>J.C.</given-names></name><name><surname>Leung</surname><given-names>E.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Targeted genome editing across species using ZFNs and TALENs</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>307</fpage><pub-id pub-id-type="doi">10.1126/science.1207773</pub-id><pub-id pub-id-type="pmid">21700836</pub-id></element-citation></ref><ref id="B111-antibiotics-09-00480"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutuli</surname><given-names>M.A.</given-names></name><name><surname>Petronio</surname><given-names>G.P.</given-names></name><name><surname>Vergalito</surname><given-names>F.</given-names></name><name><surname>Magnifico</surname><given-names>I.</given-names></name><name><surname>Pietrangelo</surname><given-names>L.</given-names></name><name><surname>Venditti</surname><given-names>N.</given-names></name><name><surname>Marco</surname><given-names>R.G.</given-names></name></person-group><article-title><italic>Galleria mellonella</italic> as a consolidated in vivo model hosts: New developments in antibacterial strategies and novel drug testing</article-title><source>Virulence</source><year>2019</year><volume>10</volume><fpage>527</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1080/21505594.2019.1621649</pub-id><pub-id pub-id-type="pmid">31142220</pub-id></element-citation></ref><ref id="B112-antibiotics-09-00480"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humann</surname><given-names>J.</given-names></name><name><surname>Lenz</surname><given-names>L.L.</given-names></name></person-group><article-title>Bacterial peptidoglycan degrading enzymes and their impact on host muropeptide detection</article-title><source>J. Innate Immun.</source><year>2009</year><volume>1</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1159/000181181</pub-id><?supplied-pmid 19319201?><pub-id pub-id-type="pmid">19319201</pub-id></element-citation></ref><ref id="B113-antibiotics-09-00480"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Upadhyaya</surname><given-names>I.</given-names></name><name><surname>Johny</surname><given-names>A.K.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Combating pathogenic microorganisms using plant-derived antimicrobials: A minireview of the mechanistic basis</article-title><source>Biomed. Res. Int.</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1155/2014/761741</pub-id><?supplied-pmid 25298964?><pub-id pub-id-type="pmid">25298964</pub-id></element-citation></ref><ref id="B114-antibiotics-09-00480"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Marais</surname><given-names>J.P.</given-names></name><name><surname>Khoo</surname><given-names>C.</given-names></name><name><surname>LaPlante</surname><given-names>K.</given-names></name><name><surname>Vejborg</surname><given-names>R.M.</given-names></name><name><surname>Givskov</surname><given-names>M.</given-names></name><name><surname>Nielsen</surname><given-names>T.T.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name><name><surname>Rowley</surname><given-names>D.C.</given-names></name></person-group><article-title>Cranberry (<italic>Vaccinium macrocarpon</italic>) oligosaccharides decrease biofilm formation by uropathogenic <italic>Escherichia coli</italic></article-title><source>J. Funct. Foods</source><year>2015</year><volume>17</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2015.05.016</pub-id><?supplied-pmid 26613004?><pub-id pub-id-type="pmid">26613004</pub-id></element-citation></ref><ref id="B115-antibiotics-09-00480"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrey</surname><given-names>R.K.</given-names></name><name><surname>Barksdale</surname><given-names>S.M.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Hoek</surname><given-names>M.L.V.</given-names></name></person-group><article-title>Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa</article-title><source>BMC Complement. Altern. Med.</source><year>2014</year><volume>14</volume><elocation-id>499</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-14-499</pub-id><?supplied-pmid 25511463?><pub-id pub-id-type="pmid">25511463</pub-id></element-citation></ref><ref id="B116-antibiotics-09-00480"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojnicz</surname><given-names>D.</given-names></name><name><surname>Goska</surname><given-names>D.T.</given-names></name><name><surname>Korzekwa</surname><given-names>K.</given-names></name><name><surname>Kicia</surname><given-names>M.</given-names></name><name><surname>Hendrich</surname><given-names>A.B.</given-names></name></person-group><article-title>Study of the impact of cranberry extract on the virulence factors and biofilm formation by <italic>Enterococcus faecalis</italic> strains isolated from urinary tract infections</article-title><source>Int. J. Food Sci. Nutr.</source><year>2016</year><volume>67</volume><fpage>1005</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1080/09637486.2016.1211996</pub-id><?supplied-pmid 27456160?><pub-id pub-id-type="pmid">27456160</pub-id></element-citation></ref><ref id="B117-antibiotics-09-00480"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushnie</surname><given-names>T.P.</given-names></name><name><surname>Lamb</surname><given-names>A.J.</given-names></name></person-group><article-title>Antimicrobial activity of flavonoids</article-title><source>Int. J. Antimicrob. Agents</source><year>2005</year><volume>26</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.09.002</pub-id><pub-id pub-id-type="pmid">16323269</pub-id></element-citation></ref><ref id="B118-antibiotics-09-00480"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>L.C.</given-names></name><name><surname>Lemos</surname><given-names>M.</given-names></name><name><surname>Pereira</surname><given-names>A.M.</given-names></name><name><surname>Abreu</surname><given-names>A.C.</given-names></name><name><surname>Saavedra</surname><given-names>M.J.</given-names></name><name><surname>Simoes</surname><given-names>M.</given-names></name></person-group><article-title>Persister cells in a biofilm treated with a biocide</article-title><source>Biofouling</source><year>2011</year><volume>27</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1080/08927014.2011.579599</pub-id><pub-id pub-id-type="pmid">21547756</pub-id></element-citation></ref><ref id="B119-antibiotics-09-00480"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>M.</given-names></name><name><surname>Haenni</surname><given-names>M.</given-names></name><name><surname>Canarelli</surname><given-names>S.</given-names></name><name><surname>Fisch</surname><given-names>F.</given-names></name><name><surname>Chodanowski</surname><given-names>P.</given-names></name><name><surname>Servis</surname><given-names>C.</given-names></name><name><surname>Michielin</surname><given-names>O.</given-names></name><name><surname>Freitag</surname><given-names>R.</given-names></name><name><surname>Moreillon</surname><given-names>P.</given-names></name><name><surname>Mermod</surname><given-names>N.</given-names></name></person-group><article-title>Structure-function characterization and optimization of a plant-derived antibacterial peptide</article-title><source>Antimicrob. Agents Chemother.</source><year>2005</year><volume>49</volume><fpage>3847</fpage><lpage>3857</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.9.3847-3857.2005</pub-id><pub-id pub-id-type="pmid">16127062</pub-id></element-citation></ref><ref id="B120-antibiotics-09-00480"><label>120.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Giacinto</surname><given-names>B.</given-names></name><name><surname>Cosentino</surname><given-names>M.</given-names></name><name><surname>Sakurada</surname><given-names>T.</given-names></name></person-group><source>Aromatherapy: Basic Mechanisms And Evidence Based Clinical Use</source><publisher-name>CRC Press Taylor Francis Group</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2016</year><fpage>174</fpage></element-citation></ref><ref id="B121-antibiotics-09-00480"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willers</surname><given-names>C.</given-names></name><name><surname>Wentzel</surname><given-names>J.F.</given-names></name><name><surname>Plessis</surname><given-names>L.H.D.</given-names></name><name><surname>Gouws</surname><given-names>C.</given-names></name><name><surname>Hamman</surname><given-names>J.H.</given-names></name></person-group><article-title>Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: The role of efflux inhibitors</article-title><source>Expert Opin. Targets</source><year>2017</year><volume>21</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1080/14728222.2017.1265105</pub-id></element-citation></ref><ref id="B122-antibiotics-09-00480"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>C.F.</given-names></name><name><surname>Hammer</surname><given-names>K.A.</given-names></name><name><surname>Riley</surname><given-names>T.V.</given-names></name></person-group><article-title><italic>Melaleuca alternifolia</italic> (Tea Tree) oil: A review of antimicrobial and other medicinal properties</article-title><source>Clin. Microbiol. Rev.</source><year>2006</year><volume>19</volume><fpage>50</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1128/CMR.19.1.50-62.2006</pub-id><pub-id pub-id-type="pmid">16418522</pub-id></element-citation></ref><ref id="B123-antibiotics-09-00480"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rad</surname><given-names>J.S.</given-names></name><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Varoni</surname><given-names>E.M.</given-names></name><name><surname>Sharopov</surname><given-names>F.</given-names></name><name><surname>Yousaf</surname><given-names>Z.</given-names></name><name><surname>Ayatollahi</surname><given-names>S.A.</given-names></name><name><surname>Kobarfard</surname><given-names>F.</given-names></name><name><surname>Rad</surname><given-names>M.S.</given-names></name><name><surname>Afdjei</surname><given-names>M.H.</given-names></name><name><surname>Iriti</surname><given-names>M.</given-names></name></person-group><article-title>Plants of the melaleuca genus as antimicrobial agents: From farm to pharmacy</article-title><source>Phytother. Res.</source><year>2017</year><volume>31</volume><fpage>1475</fpage><lpage>1494</lpage><pub-id pub-id-type="pmid">28782167</pub-id></element-citation></ref><ref id="B124-antibiotics-09-00480"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.Z.</given-names></name><name><surname>Plesiat</surname><given-names>P.</given-names></name><name><surname>Nikaido</surname><given-names>H.</given-names></name></person-group><article-title>The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria</article-title><source>Clin. Microbiol. Rev.</source><year>2015</year><volume>28</volume><fpage>337</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1128/CMR.00117-14</pub-id><?supplied-pmid 25788514?><pub-id pub-id-type="pmid">25788514</pub-id></element-citation></ref><ref id="B125-antibiotics-09-00480"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Guan</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>3215</fpage><lpage>3218</lpage><pub-id pub-id-type="doi">10.1128/AAC.00248-16</pub-id><?supplied-pmid 26953203?><pub-id pub-id-type="pmid">26953203</pub-id></element-citation></ref><ref id="B126-antibiotics-09-00480"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selim</surname><given-names>S.</given-names></name><name><surname>Alfy</surname><given-names>S.</given-names></name><name><surname>Ruwaili</surname><given-names>M.A.</given-names></name><name><surname>Abdo</surname><given-names>A.</given-names></name><name><surname>Jaouni</surname><given-names>S.A.</given-names></name></person-group><article-title>Susceptibility of imipenem-resistant <italic>Pseudomonas aeruginosa</italic> to flavonoid glycosides of date palm (<italic>Phoenix dactylifera</italic> L.) tamar growing in Al madinah, saudi arabia</article-title><source>Afr. J. Biotechnol.</source><year>2012</year><volume>11</volume><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.5897/AJB11.1412</pub-id></element-citation></ref><ref id="B127-antibiotics-09-00480"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>M.M.</given-names></name></person-group><article-title>Plant products as antimicrobial agents</article-title><source>Clin. Microbiol. Rev.</source><year>1999</year><volume>12</volume><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1128/CMR.12.4.564</pub-id><pub-id pub-id-type="pmid">10515903</pub-id></element-citation></ref><ref id="B128-antibiotics-09-00480"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eumkeb</surname><given-names>G.</given-names></name><name><surname>Sakdarat</surname><given-names>S.</given-names></name><name><surname>Siriwong</surname><given-names>S.</given-names></name></person-group><article-title>Reversing beta-lactam antibiotic resistance of <italic>Staphylococcus aureus</italic> with galangin from <italic>Alpinia officinarum</italic> hance and synergism with ceftazidime</article-title><source>Phytomedicine</source><year>2010</year><volume>18</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.09.003</pub-id><pub-id pub-id-type="pmid">21036573</pub-id></element-citation></ref><ref id="B129-antibiotics-09-00480"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eumkeb</surname><given-names>G.</given-names></name><name><surname>Siriwong</surname><given-names>S.</given-names></name><name><surname>Phitaktim</surname><given-names>S.</given-names></name><name><surname>Rojtinnakorn</surname><given-names>N.</given-names></name><name><surname>Sakdarat</surname><given-names>S.</given-names></name></person-group><article-title>Synergistic activity and mode of action of flavonoids isolated from smaller galangal and amoxicillin combinations against amoxicillin-resistant <italic>Escherichia coli</italic></article-title><source>J. Appl. Microbiol.</source><year>2012</year><volume>112</volume><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2011.05190.x</pub-id><pub-id pub-id-type="pmid">22111967</pub-id></element-citation></ref><ref id="B130-antibiotics-09-00480"><label>130.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>P.M.</given-names></name><name><surname>Naidu</surname><given-names>A.S.</given-names></name></person-group><article-title>Phyto-phenols</article-title><source>Natural Food Antimicrobial Systems</source><person-group person-group-type="editor"><name><surname>Naidu</surname><given-names>A.S.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2000</year><fpage>278</fpage><lpage>307</lpage></element-citation></ref><ref id="B131-antibiotics-09-00480"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils: Their antibacterial properties and potential applications in foods&#x02014;A review</article-title><source>Int. J. Food Microbiol.</source><year>2004</year><volume>94</volume><fpage>223</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2004.03.022</pub-id><pub-id pub-id-type="pmid">15246235</pub-id></element-citation></ref><ref id="B132-antibiotics-09-00480"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>A.O.</given-names></name><name><surname>Holley</surname><given-names>R.A.</given-names></name></person-group><article-title>Mechanisms of bactericidal action of cinnamaldehyde against <italic>Listeria monocytogenes</italic> and of eugenol against <italic>L. monocytogenes</italic> and <italic>Lactobacillus sakei</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2004</year><volume>70</volume><fpage>5750</fpage><lpage>5755</lpage><pub-id pub-id-type="doi">10.1128/AEM.70.10.5750-5755.2004</pub-id><pub-id pub-id-type="pmid">15466510</pub-id></element-citation></ref><ref id="B133-antibiotics-09-00480"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>A.O.</given-names></name><name><surname>Holley</surname><given-names>R.A.</given-names></name></person-group><article-title>Disruption of <italic>Escherichia coli</italic>, <italic>Listeria monocytogenes</italic> and <italic>Lactobacillus sakei</italic> cellular membranes by plant oil aromatics</article-title><source>Int. J. Food Microbiol.</source><year>2006</year><volume>108</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2005.10.009</pub-id><pub-id pub-id-type="pmid">16417936</pub-id></element-citation></ref><ref id="B134-antibiotics-09-00480"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>A.O.</given-names></name><name><surname>Holley</surname><given-names>R.A.</given-names></name></person-group><article-title>Inhibition of membrane bound ATPases of <italic>Escherichia coli</italic> and <italic>Listeria monocytogenes</italic> by plant oil aromatics</article-title><source>Int. J. Food Microbiol.</source><year>2006</year><volume>111</volume><fpage>170</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.04.046</pub-id><?supplied-pmid 16828188?><pub-id pub-id-type="pmid">16828188</pub-id></element-citation></ref><ref id="B135-antibiotics-09-00480"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negi</surname><given-names>P.S.</given-names></name></person-group><article-title>Plant extracts for the control of bacterial growth: Efficacy, stability and safety issues for food application</article-title><source>Int. J. Food Microbiol.</source><year>2012</year><volume>156</volume><fpage>7</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2012.03.006</pub-id><?supplied-pmid 22459761?><pub-id pub-id-type="pmid">22459761</pub-id></element-citation></ref><ref id="B136-antibiotics-09-00480"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozfenerci</surname><given-names>M.</given-names></name><name><surname>Cal&#x00131;skan</surname><given-names>U.K.</given-names></name></person-group><article-title>Tea tree oil and its use in aromatherapy</article-title><source>Curr. Pers. Maps</source><year>2018</year><volume>2</volume><fpage>90</fpage><lpage>102</lpage></element-citation></ref><ref id="B137-antibiotics-09-00480"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzi</surname><given-names>V.</given-names></name><name><surname>Muselli</surname><given-names>A.</given-names></name><name><surname>Bernardini</surname><given-names>A.F.</given-names></name><name><surname>Berti</surname><given-names>L.</given-names></name><name><surname>Pages</surname><given-names>J.M.</given-names></name><name><surname>Amaral</surname><given-names>L.</given-names></name><name><surname>Bolla</surname><given-names>J.M.</given-names></name></person-group><article-title>Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species</article-title><source>Antimicrob. Agents Chemother.</source><year>2009</year><volume>53</volume><fpage>2209</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1128/AAC.00919-08</pub-id><?supplied-pmid 19258278?><pub-id pub-id-type="pmid">19258278</pub-id></element-citation></ref><ref id="B138-antibiotics-09-00480"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aqil</surname><given-names>F.</given-names></name><name><surname>Khan</surname><given-names>M.S.</given-names></name><name><surname>Owais</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name></person-group><article-title>Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant <italic>Staphylococcus aureus</italic></article-title><source>J. Basic. Microbiol.</source><year>2005</year><volume>45</volume><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1002/jobm.200410355</pub-id><?supplied-pmid 15812867?><pub-id pub-id-type="pmid">15812867</pub-id></element-citation></ref><ref id="B139-antibiotics-09-00480"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>K.</given-names></name><name><surname>Takaishi</surname><given-names>Y.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Higuti</surname><given-names>T.</given-names></name></person-group><article-title>ILSMRs (intensifier of beta-lactam-susceptibility in methicillin-resistant <italic>Staphylococcus aureus</italic>) from tara [caesalpinia spinosa (Molina) kuntze]</article-title><source>Phytomedicine</source><year>2006</year><volume>13</volume><fpage>209</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2004.08.001</pub-id><pub-id pub-id-type="pmid">16428032</pub-id></element-citation></ref><ref id="B140-antibiotics-09-00480"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>F.F.</given-names></name><name><surname>Costa</surname><given-names>J.G.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.</given-names></name></person-group><article-title>Synergy effects of the antibiotics gentamicin and the essential oil of croton zehntneri</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>1052</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.04.004</pub-id><pub-id pub-id-type="pmid">19524417</pub-id></element-citation></ref><ref id="B141-antibiotics-09-00480"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grande</surname><given-names>M.J.</given-names></name><name><surname>Lopez</surname><given-names>R.L.</given-names></name><name><surname>Abriouel</surname><given-names>H.</given-names></name><name><surname>Valdivia</surname><given-names>E.</given-names></name><name><surname>Omar</surname><given-names>N.B.</given-names></name><name><surname>Maqueda</surname><given-names>M.</given-names></name><name><surname>Canamero</surname><given-names>M.M.</given-names></name><name><surname>Galvez</surname><given-names>A.</given-names></name></person-group><article-title>Treatment of vegetable sauces with enterocin AS-48 alone or in combination with phenolic compounds to inhibit proliferation of <italic>Staphylococcus aureus</italic></article-title><source>J. Food Prot.</source><year>2007</year><volume>70</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.4315/0362-028X-70.2.405</pub-id><pub-id pub-id-type="pmid">17340876</pub-id></element-citation></ref><ref id="B142-antibiotics-09-00480"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>B.C.</given-names></name><name><surname>Ip</surname><given-names>M.</given-names></name><name><surname>Lau</surname><given-names>C.B.</given-names></name><name><surname>Lui</surname><given-names>S.L.</given-names></name><name><surname>Jolivalt</surname><given-names>C.</given-names></name><name><surname>Elbaz</surname><given-names>C.G.</given-names></name><name><surname>Litaudon</surname><given-names>M.</given-names></name><name><surname>Reiner</surname><given-names>N.E.</given-names></name><name><surname>Gong</surname><given-names>H.</given-names></name><name><surname>See</surname><given-names>R.H.</given-names></name><etal/></person-group><article-title>Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) and inhibition of MRSA pyruvate kinase</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>137</volume><fpage>767</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.06.039</pub-id><pub-id pub-id-type="pmid">21782012</pub-id></element-citation></ref><ref id="B143-antibiotics-09-00480"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H.</given-names></name></person-group><article-title>Porins and specific diffusion channels in bacterial outer membranes</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>3905</fpage><lpage>3908</lpage><pub-id pub-id-type="pmid">7508433</pub-id></element-citation></ref><ref id="B144-antibiotics-09-00480"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieboji</surname><given-names>J.G.</given-names></name><name><surname>Baurin</surname><given-names>S.</given-names></name><name><surname>Frere</surname><given-names>J.M.</given-names></name><name><surname>Ngassam</surname><given-names>P.</given-names></name><name><surname>Ngameni</surname><given-names>B.</given-names></name><name><surname>Azebaze</surname><given-names>A.</given-names></name><name><surname>Pegnyemb</surname><given-names>D.E.</given-names></name><name><surname>Watchueng</surname><given-names>J.</given-names></name><name><surname>Goffin</surname><given-names>C.</given-names></name><name><surname>Galleni</surname><given-names>M.</given-names></name></person-group><article-title>Screening of some medicinal plants from cameroon for beta-lactamase inhibitory activity</article-title><source>Phytother. Res.</source><year>2007</year><volume>21</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1002/ptr.2001</pub-id><pub-id pub-id-type="pmid">17221939</pub-id></element-citation></ref><ref id="B145-antibiotics-09-00480"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W.H.</given-names></name><name><surname>Hu</surname><given-names>Z.Q.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Shimamura</surname><given-names>T.</given-names></name></person-group><article-title>Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing <italic>Staphylococcus aureus</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2002</year><volume>46</volume><fpage>2266</fpage><lpage>2268</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.7.2266-2268.2002</pub-id><pub-id pub-id-type="pmid">12069986</pub-id></element-citation></ref><ref id="B146-antibiotics-09-00480"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johny</surname><given-names>A.K.</given-names></name><name><surname>Hoagland</surname><given-names>T.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Effect of subinhibitory concentrations of plant-derived molecules in increasing the sensitivity of multidrug-resistant <italic>Salmonella enterica</italic> serovar typhimurium DT104 to antibiotics</article-title><source>Foodborne Pathog. Dis.</source><year>2010</year><volume>7</volume><fpage>1165</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1089/fpd.2009.0527</pub-id><?supplied-pmid 20618084?><pub-id pub-id-type="pmid">20618084</pub-id></element-citation></ref><ref id="B147-antibiotics-09-00480"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moussaoui</surname><given-names>F.</given-names></name><name><surname>Alaoui</surname><given-names>T.</given-names></name></person-group><article-title>Evaluation of antibacterial activity and synergistic effect between antibiotic and the essential oils of some medicinal plants</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2016</year><volume>6</volume><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2015.09.024</pub-id></element-citation></ref><ref id="B148-antibiotics-09-00480"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senatore</surname><given-names>F.</given-names></name><name><surname>Rigano</surname><given-names>D.</given-names></name><name><surname>Fusco</surname><given-names>R.D.</given-names></name><name><surname>Bruno</surname><given-names>M.</given-names></name></person-group><article-title>Composition of the essential oil from flowerheads of <italic>Chrysanthemum coronarium</italic> L. (Asteraceae) growing wild in southern italy</article-title><source>Flavour. Fragr.</source><year>2004</year><volume>19</volume><fpage>149</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1002/ffj.1285</pub-id></element-citation></ref><ref id="B149-antibiotics-09-00480"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>M.E.</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>G.A.</given-names></name></person-group><article-title>Microbial biofilms: From ecology to molecular genetics</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2000</year><volume>64</volume><fpage>847</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1128/MMBR.64.4.847-867.2000</pub-id><?supplied-pmid 11104821?><pub-id pub-id-type="pmid">11104821</pub-id></element-citation></ref><ref id="B150-antibiotics-09-00480"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chmielewski</surname><given-names>R.A.N.</given-names></name><name><surname>Frank</surname><given-names>J.F.</given-names></name></person-group><article-title>Biofilm formation and control in food processing facilities</article-title><source>Compr. Rev. Food Sci. Food Saf.</source><year>2003</year><volume>2</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1111/j.1541-4337.2003.tb00012.x</pub-id></element-citation></ref><ref id="B151-antibiotics-09-00480"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flemming</surname><given-names>H.C.</given-names></name><name><surname>Wingender</surname><given-names>J.</given-names></name></person-group><article-title>The biofilm matrix</article-title><source>Nat. Rev. Microbiol.</source><year>2010</year><volume>8</volume><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2415</pub-id><?supplied-pmid 20676145?><pub-id pub-id-type="pmid">20676145</pub-id></element-citation></ref><ref id="B152-antibiotics-09-00480"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langsrud</surname><given-names>S.</given-names></name><name><surname>Sidhu</surname><given-names>M.S.</given-names></name><name><surname>Heir</surname><given-names>E.</given-names></name><name><surname>Holck</surname><given-names>A.L.</given-names></name></person-group><article-title>Bacterial disinfectant resistance&#x02014;A challenge for the food industry</article-title><source>Int. Biodeterior. Biodegrad.</source><year>2003</year><volume>51</volume><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/S0964-8305(03)00039-8</pub-id></element-citation></ref><ref id="B153-antibiotics-09-00480"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>R.N.</given-names></name><name><surname>Rosa</surname><given-names>E.A.</given-names></name></person-group><article-title>Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>746</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1039/b821648g</pub-id><pub-id pub-id-type="pmid">19471683</pub-id></element-citation></ref><ref id="B154-antibiotics-09-00480"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>M.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>L.C.</given-names></name><name><surname>Machado</surname><given-names>I.</given-names></name><name><surname>Pereira</surname><given-names>M.O.</given-names></name><name><surname>Vieira</surname><given-names>M.J.</given-names></name></person-group><article-title>Control of flow-generated biofilms with surfactants: Evidence of resistance and recovery</article-title><source>Food Bioprod. Proces.</source><year>2006</year><volume>84</volume><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1205/fbp06022</pub-id></element-citation></ref><ref id="B155-antibiotics-09-00480"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Upadhyaya</surname><given-names>I.</given-names></name><name><surname>Johny</surname><given-names>A.K.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Antibiofilm effect of plant derived antimicrobials on <italic>Listeria monocytogenes</italic></article-title><source>Food Microbiol.</source><year>2013</year><volume>36</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2013.04.010</pub-id><?supplied-pmid 23764223?><pub-id pub-id-type="pmid">23764223</pub-id></element-citation></ref><ref id="B156-antibiotics-09-00480"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Marino</surname><given-names>A.</given-names></name><name><surname>Blanco</surname><given-names>A.R.</given-names></name><name><surname>Cellini</surname><given-names>L.</given-names></name><name><surname>Di Giulio</surname><given-names>M.</given-names></name><name><surname>Pizzimenti</surname><given-names>F.</given-names></name><name><surname>Roccaro</surname><given-names>A.S.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name></person-group><article-title>In vitro activity of carvacrol against staphylococcal preformed biofilm by liquid and vapour contact</article-title><source>J. Med. Microbiol.</source><year>2009</year><volume>58</volume><fpage>791</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.009274-0</pub-id><pub-id pub-id-type="pmid">19429756</pub-id></element-citation></ref><ref id="B157-antibiotics-09-00480"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Scaffaro</surname><given-names>R.</given-names></name><name><surname>D&#x02019;Arrigo</surname><given-names>M.</given-names></name><name><surname>Botta</surname><given-names>L.</given-names></name><name><surname>Filocamo</surname><given-names>A.</given-names></name><name><surname>Marino</surname><given-names>A.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name></person-group><article-title>Study on carvacrol and cinnamaldehyde polymeric films: Mechanical properties, release kinetics and antibacterial and antibiofilm activities</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>96</volume><fpage>1029</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4091-3</pub-id><pub-id pub-id-type="pmid">22555914</pub-id></element-citation></ref><ref id="B158-antibiotics-09-00480"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Sudano Roccaro</surname><given-names>A.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name><name><surname>Marino</surname><given-names>A.</given-names></name><name><surname>Cannatelli</surname><given-names>M.A.</given-names></name><name><surname>Pizzimenti</surname><given-names>F.C.</given-names></name><name><surname>Cioni</surname><given-names>P.L.</given-names></name><name><surname>Procopio</surname><given-names>F.</given-names></name><name><surname>Blanco</surname><given-names>A.R.</given-names></name></person-group><article-title>Effects of oregano, carvacrol and thymol on <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic> biofilms</article-title><source>J. Med. Microbiol.</source><year>2007</year><volume>56</volume><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.46804-0</pub-id><pub-id pub-id-type="pmid">17374894</pub-id></element-citation></ref><ref id="B159-antibiotics-09-00480"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walencka</surname><given-names>E.</given-names></name><name><surname>Rozalska</surname><given-names>S.</given-names></name><name><surname>Wysokinska</surname><given-names>H.</given-names></name><name><surname>Rozalski</surname><given-names>M.</given-names></name><name><surname>Kuzma</surname><given-names>L.</given-names></name><name><surname>Rozalska</surname><given-names>B.</given-names></name></person-group><article-title>Salvipisone and aethiopinone from salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity</article-title><source>Planta Med.</source><year>2007</year><volume>73</volume><fpage>545</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1055/s-2007-967179</pub-id><pub-id pub-id-type="pmid">17650545</pub-id></element-citation></ref><ref id="B160-antibiotics-09-00480"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakri</surname><given-names>A.G.A.</given-names></name><name><surname>Othman</surname><given-names>G.</given-names></name><name><surname>Afifi</surname><given-names>F.U.</given-names></name></person-group><article-title>Determination of the antibiofilm, antiadhesive, and anti-MRSA activities of seven salvia species</article-title><source>Pharm. Mag.</source><year>2010</year><volume>6</volume><fpage>264</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.4103/0973-1296.71786</pub-id></element-citation></ref><ref id="B161-antibiotics-09-00480"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Givskov</surname><given-names>M.</given-names></name><name><surname>Molin</surname><given-names>S.</given-names></name><name><surname>Hoiby</surname><given-names>N.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><article-title>Effects of ginseng on <italic>Pseudomonas aeruginosa</italic> motility and biofilm formation</article-title><source>FEMS Immunol. Med. Microbiol.</source><year>2011</year><volume>62</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2011.00787.x</pub-id><pub-id pub-id-type="pmid">21303421</pub-id></element-citation></ref><ref id="B162-antibiotics-09-00480"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>K.</given-names></name><name><surname>Anderson</surname><given-names>D.</given-names></name><name><surname>Dan</surname><given-names>A.</given-names></name></person-group><article-title>Inhibiting biofilm formation of <italic>Pseudomonas aeruginosa</italic>: A two-pronged attack</article-title><source>Young Sci. J.</source><year>2009</year><volume>2</volume><fpage>8</fpage><lpage>13</lpage></element-citation></ref><ref id="B163-antibiotics-09-00480"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grudniak</surname><given-names>A.M.</given-names></name><name><surname>Kurek</surname><given-names>A.</given-names></name><name><surname>Szarlak</surname><given-names>J.</given-names></name><name><surname>Wolska</surname><given-names>K.I.</given-names></name></person-group><article-title>Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in <italic>Escherichia coli</italic></article-title><source>Curr. Microbiol.</source><year>2011</year><volume>62</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1007/s00284-010-9866-0</pub-id><pub-id pub-id-type="pmid">21221969</pub-id></element-citation></ref><ref id="B164-antibiotics-09-00480"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>D.</given-names></name><name><surname>Zuo</surname><given-names>R.</given-names></name><name><surname>Barrios</surname><given-names>A.F.G.</given-names></name><name><surname>Bedzyk</surname><given-names>L.A.</given-names></name><name><surname>Eldridge</surname><given-names>G.R.</given-names></name><name><surname>Pasmore</surname><given-names>M.E.</given-names></name><name><surname>Wood</surname><given-names>T.K.</given-names></name></person-group><article-title>Differential gene expression for investigation of <italic>Escherichia coli</italic> biofilm inhibition by plant extract ursolic acid</article-title><source>Appl. Environ. Microbiol.</source><year>2005</year><volume>71</volume><fpage>4022</fpage><lpage>4034</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.7.4022-4034.2005</pub-id><?supplied-pmid 16000817?><pub-id pub-id-type="pmid">16000817</pub-id></element-citation></ref><ref id="B165-antibiotics-09-00480"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amalaradjou</surname><given-names>M.A.</given-names></name><name><surname>Narayanan</surname><given-names>A.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic <italic>Escherichia coli</italic> in urinary tract epithelial cells by modulating virulence gene expression</article-title><source>J. Urol.</source><year>2011</year><volume>185</volume><fpage>1526</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2010.11.078</pub-id><?supplied-pmid 21334666?><pub-id pub-id-type="pmid">21334666</pub-id></element-citation></ref><ref id="B166-antibiotics-09-00480"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>E.B.</given-names></name><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Tsui</surname><given-names>W.</given-names></name><name><surname>McClure</surname><given-names>J.</given-names></name><name><surname>Surette</surname><given-names>M.G.</given-names></name><name><surname>Davies</surname><given-names>J.</given-names></name></person-group><article-title>Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics</article-title><source>Proc. Natl. Acad. Sci USA</source><year>2002</year><volume>99</volume><fpage>17025</fpage><lpage>17030</lpage><pub-id pub-id-type="doi">10.1073/pnas.252607699</pub-id><?supplied-pmid 12482953?><pub-id pub-id-type="pmid">12482953</pub-id></element-citation></ref><ref id="B167-antibiotics-09-00480"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name></person-group><article-title>Eugenol reduces the expression of virulence-related exoproteins in <italic>Staphylococcus aureus</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2010</year><volume>76</volume><fpage>5846</fpage><lpage>5851</lpage><pub-id pub-id-type="doi">10.1128/AEM.00704-10</pub-id><?supplied-pmid 20639367?><pub-id pub-id-type="pmid">20639367</pub-id></element-citation></ref><ref id="B168-antibiotics-09-00480"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>W.H.</given-names></name><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>H.H.</given-names></name><name><surname>McClure</surname><given-names>J.E.</given-names></name><name><surname>Surette</surname><given-names>M.G.</given-names></name><name><surname>Davies</surname><given-names>J.</given-names></name></person-group><article-title>Dual effects of MLS antibiotics: Transcriptional modulation and interactions on the ribosome</article-title><source>Chem. Biol.</source><year>2004</year><volume>11</volume><fpage>1307</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2004.07.010</pub-id><pub-id pub-id-type="pmid">15380191</pub-id></element-citation></ref><ref id="B169-antibiotics-09-00480"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Johny</surname><given-names>A.K.</given-names></name><name><surname>Amalaradjou</surname><given-names>M.A.</given-names></name><name><surname>Baskaran</surname><given-names>S.A.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Plant-derived antimicrobials reduce <italic>Listeria monocytogenes</italic> virulence factors in vitro, and down-regulate expression of virulence genes</article-title><source>Int. J. Food Microbiol.</source><year>2012</year><volume>157</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2012.04.018</pub-id><pub-id pub-id-type="pmid">22608657</pub-id></element-citation></ref><ref id="B170-antibiotics-09-00480"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>McClure</surname><given-names>J.</given-names></name><name><surname>Surette</surname><given-names>M.G.</given-names></name><name><surname>Davies</surname><given-names>J.E.</given-names></name></person-group><article-title>Modulation of salmonella gene expression by subinhibitory concentrations of quinolones</article-title><source>J. Antibiot</source><year>2011</year><volume>64</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/ja.2010.137</pub-id><pub-id pub-id-type="pmid">21102598</pub-id></element-citation></ref><ref id="B171-antibiotics-09-00480"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brackman</surname><given-names>G.</given-names></name><name><surname>Defoirdt</surname><given-names>T.</given-names></name><name><surname>Miyamoto</surname><given-names>C.</given-names></name><name><surname>Bossier</surname><given-names>P.</given-names></name><name><surname>Calenbergh</surname><given-names>S.V.</given-names></name><name><surname>Nelis</surname><given-names>H.</given-names></name><name><surname>Coenye</surname><given-names>T.</given-names></name></person-group><article-title>Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR</article-title><source>BMC Microbiol.</source><year>2008</year><volume>8</volume><elocation-id>149</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-8-149</pub-id><pub-id pub-id-type="pmid">18793453</pub-id></element-citation></ref><ref id="B172-antibiotics-09-00480"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Woo</surname><given-names>J.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name></person-group><article-title>Cellular and molecular responses of salmonella typhimurium to antimicrobial-induced stresses during the planktonic-to-biofilm transition</article-title><source>Lett. Appl. Microbiol.</source><year>2012</year><volume>55</volume><fpage>274</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2012.03288.x</pub-id><pub-id pub-id-type="pmid">22803575</pub-id></element-citation></ref><ref id="B173-antibiotics-09-00480"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname><given-names>T.H.</given-names></name><name><surname>Gennip</surname><given-names>M.V.</given-names></name><name><surname>Phipps</surname><given-names>R.K.</given-names></name><name><surname>Shanmugham</surname><given-names>M.S.</given-names></name><name><surname>Christensen</surname><given-names>L.D.</given-names></name><name><surname>Alhede</surname><given-names>M.</given-names></name><name><surname>Skindersoe</surname><given-names>M.E.</given-names></name><name><surname>Rasmussen</surname><given-names>T.B.</given-names></name><name><surname>Friedrich</surname><given-names>K.</given-names></name><name><surname>Uthe</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing</article-title><source>Antimicrob. Agents Chemother.</source><year>2012</year><volume>56</volume><fpage>2314</fpage><lpage>2325</lpage><pub-id pub-id-type="doi">10.1128/AAC.05919-11</pub-id><pub-id pub-id-type="pmid">22314537</pub-id></element-citation></ref><ref id="B174-antibiotics-09-00480"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amalaradjou</surname><given-names>M.A.</given-names></name><name><surname>Narayanan</surname><given-names>A.</given-names></name><name><surname>Baskaran</surname><given-names>S.A.</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K.</given-names></name></person-group><article-title>Antibiofilm effect of trans-cinnamaldehyde on uropathogenic <italic>Escherichia coli</italic></article-title><source>J. Urol.</source><year>2010</year><volume>184</volume><fpage>358</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2010.03.006</pub-id><pub-id pub-id-type="pmid">20488489</pub-id></element-citation></ref><ref id="B175-antibiotics-09-00480"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalleau</surname><given-names>S.</given-names></name><name><surname>Cateau</surname><given-names>E.</given-names></name><name><surname>Berges</surname><given-names>T.</given-names></name><name><surname>Berjeaud</surname><given-names>J.M.</given-names></name><name><surname>Imbert</surname><given-names>C.</given-names></name></person-group><article-title>In vitro activity of terpenes against candida biofilms</article-title><source>Int. J. Antimicrob. Agents</source><year>2008</year><volume>31</volume><fpage>572</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.01.028</pub-id><?supplied-pmid 18440786?><pub-id pub-id-type="pmid">18440786</pub-id></element-citation></ref><ref id="B176-antibiotics-09-00480"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.S.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name></person-group><article-title>Biofilm inhibition by cymbopogon citratus and syzygium aromaticum essential oils in the strains of <italic>Candida albicans</italic></article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>140</volume><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.01.045</pub-id><?supplied-pmid 22326355?><pub-id pub-id-type="pmid">22326355</pub-id></element-citation></ref><ref id="B177-antibiotics-09-00480"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowles</surname><given-names>J.R.</given-names></name><name><surname>Roller</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>D.B.</given-names></name><name><surname>Naidu</surname><given-names>A.S.</given-names></name></person-group><article-title>Antimicrobial action of carvacrol at different stages of dual-species biofilm development by <italic>Staphylococcus aureus</italic> and <italic>Salmonella enterica</italic> serovar typhimurium</article-title><source>Appl. Environ. Microbiol.</source><year>2005</year><volume>71</volume><fpage>797</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.2.797-803.2005</pub-id><?supplied-pmid 15691933?><pub-id pub-id-type="pmid">15691933</pub-id></element-citation></ref><ref id="B178-antibiotics-09-00480"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname><given-names>L.C.</given-names></name><name><surname>Ferreira</surname><given-names>R.B.</given-names></name></person-group><article-title>Intercellular communication in bacteria</article-title><source>Crit. Rev. Microbiol.</source><year>2009</year><volume>35</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1080/10408410902733946</pub-id><?supplied-pmid 19514909?><pub-id pub-id-type="pmid">19514909</pub-id></element-citation></ref><ref id="B179-antibiotics-09-00480"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname><given-names>R.P.</given-names></name><name><surname>Geisinger</surname><given-names>E.</given-names></name></person-group><article-title>Quorum sensing in staphylococci</article-title><source>Annu. Rev. Genet.</source><year>2008</year><volume>42</volume><fpage>541</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.42.110807.091640</pub-id><pub-id pub-id-type="pmid">18713030</pub-id></element-citation></ref><ref id="B180-antibiotics-09-00480"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>T.</given-names></name><name><surname>O&#x02019;Mahony</surname><given-names>R.</given-names></name><name><surname>Baird</surname><given-names>A.W.</given-names></name><name><surname>Drudy</surname><given-names>D.</given-names></name><name><surname>Whyte</surname><given-names>P.</given-names></name><name><surname>Fanning</surname><given-names>S.</given-names></name></person-group><article-title>Multi-drug resistance in <italic>Salmonella enterica</italic>: Efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters</article-title><source>Curr. Drug Targets</source><year>2006</year><volume>7</volume><fpage>849</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.2174/138945006777709548</pub-id><pub-id pub-id-type="pmid">16842216</pub-id></element-citation></ref><ref id="B181-antibiotics-09-00480"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adonizio</surname><given-names>A.L.</given-names></name><name><surname>Downum</surname><given-names>K.</given-names></name><name><surname>Bennett</surname><given-names>B.C.</given-names></name><name><surname>Mathee</surname><given-names>K.</given-names></name></person-group><article-title>Anti-quorum sensing activity of medicinal plants in southern florida</article-title><source>J. Ethnopharmacol.</source><year>2006</year><volume>105</volume><fpage>427</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.11.025</pub-id><pub-id pub-id-type="pmid">16406418</pub-id></element-citation></ref><ref id="B182-antibiotics-09-00480"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>W.D.</given-names></name><name><surname>Mathesius</surname><given-names>U.</given-names></name></person-group><article-title>Plant responses to bacterial quorum sensing signals</article-title><source>Curr. Opin. Plant Biol.</source><year>2004</year><volume>7</volume><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.pbi.2004.05.008</pub-id><pub-id pub-id-type="pmid">15231266</pub-id></element-citation></ref><ref id="B183-antibiotics-09-00480"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teplitski</surname><given-names>M.</given-names></name><name><surname>Robinson</surname><given-names>J.B.</given-names></name><name><surname>Bauer</surname><given-names>W.D.</given-names></name></person-group><article-title>Plants secrete substances that mimic bacterial N-acyl homoserine lactone signal activities and affect population density-dependent behaviors in associated bacteria</article-title><source>Mol. Plant. Microbe Interact.</source><year>2000</year><volume>13</volume><fpage>637</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1094/MPMI.2000.13.6.637</pub-id><pub-id pub-id-type="pmid">10830263</pub-id></element-citation></ref><ref id="B184-antibiotics-09-00480"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodini</surname><given-names>S.F.</given-names></name><name><surname>Manfredini</surname><given-names>S.</given-names></name><name><surname>Epp</surname><given-names>M.</given-names></name><name><surname>Valentini</surname><given-names>S.</given-names></name><name><surname>Santori</surname><given-names>F.</given-names></name></person-group><article-title>Quorum sensing inhibition activity of garlic extract and p-coumaric acid</article-title><source>Lett. Appl. Microbiol.</source><year>2009</year><volume>49</volume><fpage>551</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1111/j.1472-765X.2009.02704.x</pub-id><?supplied-pmid 19709367?><pub-id pub-id-type="pmid">19709367</pub-id></element-citation></ref><ref id="B185-antibiotics-09-00480"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cech</surname><given-names>N.B.</given-names></name><name><surname>Junio</surname><given-names>H.A.</given-names></name><name><surname>Ackermann</surname><given-names>L.W.</given-names></name><name><surname>Kavanaugh</surname><given-names>J.S.</given-names></name><name><surname>Horswill</surname><given-names>A.R.</given-names></name></person-group><article-title>Quorum quenching and antimicrobial activity of goldenseal (<italic>Hydrastis canadensis</italic>) against methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA)</article-title><source>Planta Med.</source><year>2012</year><volume>78</volume><fpage>1556</fpage><lpage>1561</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1315042</pub-id><?supplied-pmid 22814821?><pub-id pub-id-type="pmid">22814821</pub-id></element-citation></ref><ref id="B186-antibiotics-09-00480"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talekar</surname><given-names>S.J.</given-names></name><name><surname>Chochua</surname><given-names>S.</given-names></name><name><surname>Nelson</surname><given-names>K.</given-names></name><name><surname>Klugman</surname><given-names>K.P.</given-names></name><name><surname>Quave</surname><given-names>C.L.</given-names></name><name><surname>Vidal</surname><given-names>J.E.</given-names></name></person-group><article-title>220D-F2 from rubus ulmifolius kills <italic>Streptococcus pneumoniae</italic> planktonic cells and pneumococcal biofilms</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e97314</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0097314</pub-id><?supplied-pmid 24823499?><pub-id pub-id-type="pmid">24823499</pub-id></element-citation></ref><ref id="B187-antibiotics-09-00480"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazargani</surname><given-names>M.M.</given-names></name><name><surname>Rohloff</surname><given-names>J.</given-names></name></person-group><article-title>Antibiofilm activity of essential oils and plant extracts against <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> biofilms</article-title><source>Food Control.</source><year>2016</year><volume>61</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2015.09.036</pub-id></element-citation></ref><ref id="B188-antibiotics-09-00480"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>K.</given-names></name><name><surname>Phillips</surname><given-names>C.</given-names></name></person-group><article-title>The mechanism of action of a citrus oil blend against <italic>Enterococcus faecium</italic> and <italic>Enterococcus faecalis</italic></article-title><source>J. Appl. Microbiol.</source><year>2009</year><volume>106</volume><fpage>1343</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2008.04102.x</pub-id><pub-id pub-id-type="pmid">19187138</pub-id></element-citation></ref><ref id="B189-antibiotics-09-00480"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huskins</surname><given-names>W.C.</given-names></name><name><surname>Huckabee</surname><given-names>C.M.</given-names></name><name><surname>O&#x02019;Grady</surname><given-names>N.P.</given-names></name><name><surname>Murray</surname><given-names>P.</given-names></name><name><surname>Kopetskie</surname><given-names>H.</given-names></name><name><surname>Zimmer</surname><given-names>L.</given-names></name><name><surname>Walker</surname><given-names>M.E.</given-names></name><name><surname>Cochran</surname><given-names>R.L.S.</given-names></name><name><surname>Jernigan</surname><given-names>J.A.</given-names></name><name><surname>Samore</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Intervention to reduce transmission of resistant bacteria in intensive care</article-title><source>N. Engl. J. Med.</source><year>2011</year><volume>364</volume><fpage>1407</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1000373</pub-id><pub-id pub-id-type="pmid">21488763</pub-id></element-citation></ref><ref id="B190-antibiotics-09-00480"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulyaningsih</surname><given-names>S.</given-names></name><name><surname>Youns</surname><given-names>M.</given-names></name><name><surname>Readi</surname><given-names>M.Z.E.</given-names></name><name><surname>Ashour</surname><given-names>M.L.</given-names></name><name><surname>Nibret</surname><given-names>E.</given-names></name><name><surname>Sporer</surname><given-names>F.</given-names></name><name><surname>Herrmann</surname><given-names>F.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name></person-group><article-title>Biological activity of the essential oil of <italic>Kadsura longipedunculata</italic> (Schisandraceae) and its major components</article-title><source>J. Pharm. Pharm.</source><year>2010</year><volume>62</volume><fpage>1037</fpage><lpage>1044</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.2010.01119.x</pub-id></element-citation></ref><ref id="B191-antibiotics-09-00480"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zomorodian</surname><given-names>K.</given-names></name><name><surname>Saharkhiz</surname><given-names>M.J.</given-names></name><name><surname>Rahimi</surname><given-names>M.J.</given-names></name><name><surname>Bandegi</surname><given-names>A.</given-names></name><name><surname>Shekarkhar</surname><given-names>G.</given-names></name><name><surname>Bandegani</surname><given-names>A.</given-names></name><name><surname>Pakshir</surname><given-names>K.</given-names></name><name><surname>Bazargani</surname><given-names>A.</given-names></name></person-group><article-title>Chemical composition and antimicrobial activities of the essential oils from three ecotypes of <italic>Zataria multiflora</italic></article-title><source>Pharm. Mag.</source><year>2011</year><volume>7</volume><fpage>53</fpage><lpage>59</lpage></element-citation></ref><ref id="B192-antibiotics-09-00480"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobby</surname><given-names>G.H.</given-names></name><name><surname>Quave</surname><given-names>C.L.</given-names></name><name><surname>Nelson</surname><given-names>K.</given-names></name><name><surname>Compadre</surname><given-names>C.M.</given-names></name><name><surname>Beenken</surname><given-names>K.E.</given-names></name><name><surname>Smeltzer</surname><given-names>M.S.</given-names></name></person-group><article-title>Quercus cerris extracts limit <italic>Staphylococcus aureus</italic> biofilm formation</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>144</volume><fpage>812</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.10.042</pub-id><pub-id pub-id-type="pmid">23127649</pub-id></element-citation></ref><ref id="B193-antibiotics-09-00480"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranfaing</surname><given-names>J.</given-names></name><name><surname>Remy</surname><given-names>C.D.</given-names></name><name><surname>Lavigne</surname><given-names>J.P.</given-names></name><name><surname>Sotto</surname><given-names>A.</given-names></name></person-group><article-title>Propolis potentiates the effect of cranberry (<italic>Vaccinium macrocarpon</italic>) in reducing the motility and the biofilm formation of uropathogenic <italic>Escherichia coli</italic></article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0202609</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0202609</pub-id><pub-id pub-id-type="pmid">30138443</pub-id></element-citation></ref><ref id="B194-antibiotics-09-00480"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyams</surname><given-names>C.</given-names></name><name><surname>Camberlein</surname><given-names>E.</given-names></name><name><surname>Cohen</surname><given-names>J.M.</given-names></name><name><surname>Bax</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>J.S.</given-names></name></person-group><article-title>The <italic>Streptococcus pneumoniae</italic> capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms</article-title><source>Infect. Immun.</source><year>2010</year><volume>78</volume><fpage>704</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1128/IAI.00881-09</pub-id><pub-id pub-id-type="pmid">19948837</pub-id></element-citation></ref><ref id="B195-antibiotics-09-00480"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>M.E.</given-names></name><name><surname>Norcross</surname><given-names>E.W.</given-names></name><name><surname>Robertson</surname><given-names>Z.M.</given-names></name><name><surname>Moore</surname><given-names>Q.C.</given-names></name><name><surname>Fratkin</surname><given-names>J.</given-names></name><name><surname>Marquart</surname><given-names>M.E.</given-names></name></person-group><article-title>The <italic>Streptococcus pneumoniae</italic> capsule is required for full virulence in pneumococcal endophthalmitis</article-title><source>Invest. Ophthalmol. Vis. Sci.</source><year>2011</year><volume>52</volume><fpage>865</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1167/iovs.10-5513</pub-id><?supplied-pmid 21051708?><pub-id pub-id-type="pmid">21051708</pub-id></element-citation></ref><ref id="B196-antibiotics-09-00480"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Riordan</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.C.</given-names></name></person-group><article-title>Staphylococcus aureus capsular polysaccharides</article-title><source>Clin. Microbiol. Rev.</source><year>2004</year><volume>17</volume><fpage>218</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1128/CMR.17.1.218-234.2004</pub-id><?supplied-pmid 14726462?><pub-id pub-id-type="pmid">14726462</pub-id></element-citation></ref><ref id="B197-antibiotics-09-00480"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potera</surname><given-names>C.</given-names></name></person-group><article-title>Forging a link between biofilms and disease</article-title><source>Science</source><year>1999</year><volume>283</volume><fpage>1837</fpage><lpage>1839</lpage><pub-id pub-id-type="doi">10.1126/science.283.5409.1837</pub-id><?supplied-pmid 10206887?><pub-id pub-id-type="pmid">10206887</pub-id></element-citation></ref><ref id="B198-antibiotics-09-00480"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>C.M.</given-names></name><name><surname>Roberts</surname><given-names>I.S.</given-names></name></person-group><article-title>Capsular polysaccharides and their role in virulence</article-title><source>Contrib. Microbiol.</source><year>2005</year><volume>12</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">15496776</pub-id></element-citation></ref><ref id="B199-antibiotics-09-00480"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johny</surname><given-names>A.K.</given-names></name><name><surname>Mattson</surname><given-names>T.</given-names></name><name><surname>Baskaran</surname><given-names>S.A.</given-names></name><name><surname>Amalaradjou</surname><given-names>M.A.</given-names></name><name><surname>Babapoor</surname><given-names>S.</given-names></name><name><surname>March</surname><given-names>B.</given-names></name><name><surname>Valipe</surname><given-names>S.</given-names></name><name><surname>Darre</surname><given-names>M.</given-names></name><name><surname>Hoagland</surname><given-names>T.</given-names></name><name><surname>Schreiber</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Reduction of salmonella enterica <italic>Serovar enteritidis</italic> colonization in 20-day-old broiler chickens by the plant-derived compounds trans-cinnamaldehyde and eugenol</article-title><source>Appl. Environ. Microbiol.</source><year>2012</year><volume>78</volume><fpage>2981</fpage><lpage>2987</lpage><pub-id pub-id-type="doi">10.1128/AEM.07643-11</pub-id><pub-id pub-id-type="pmid">22327574</pub-id></element-citation></ref><ref id="B200-antibiotics-09-00480"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derakhshan</surname><given-names>S.</given-names></name><name><surname>Sattari</surname><given-names>M.</given-names></name><name><surname>Bigdeli</surname><given-names>M.</given-names></name></person-group><article-title>Effect of subinhibitory concentrations of cumin (<italic>Cuminum cyminum</italic> L.) seed essential oil and alcoholic extract on the morphology, capsule expression and urease activity of klebsiella pneumoniae</article-title><source>Int. J. Antimicrob. Agents</source><year>2008</year><volume>32</volume><fpage>432</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.05.009</pub-id><pub-id pub-id-type="pmid">18715764</pub-id></element-citation></ref><ref id="B201-antibiotics-09-00480"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>J.</given-names></name></person-group><article-title>The salicylic acid loop in plant defense</article-title><source>Curr. Opin. Plant. Biol.</source><year>2003</year><volume>6</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/S1369-5266(03)00058-X</pub-id><pub-id pub-id-type="pmid">12873532</pub-id></element-citation></ref><ref id="B202-antibiotics-09-00480"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.T.</given-names></name><name><surname>Stewart</surname><given-names>P.S.</given-names></name></person-group><article-title>Reduction of polysaccharide production in <italic>Pseudomonas aeruginosa</italic> biofilms by bismuth dimercaprol (BisBAL) treatment</article-title><source>J. Antimicrob. Chemother.</source><year>1999</year><volume>44</volume><fpage>601</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1093/jac/44.5.601</pub-id><pub-id pub-id-type="pmid">10552975</pub-id></element-citation></ref><ref id="B203-antibiotics-09-00480"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehreen</surname><given-names>A.</given-names></name><name><surname>Waheed</surname><given-names>M.</given-names></name><name><surname>Liaqat</surname><given-names>I.</given-names></name><name><surname>Arshad</surname><given-names>N.</given-names></name></person-group><article-title>Phytochemical, antimicrobial, and toxicological evaluation of traditional herbs used to treat sore throat</article-title><source>Biomed. Res. Int.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1155/2016/8503426</pub-id></element-citation></ref><ref id="B204-antibiotics-09-00480"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altemimi</surname><given-names>A.</given-names></name><name><surname>Lakhssassi</surname><given-names>N.</given-names></name><name><surname>Baharlouei</surname><given-names>A.</given-names></name><name><surname>Watson</surname><given-names>D.G.</given-names></name><name><surname>Lightfoot</surname><given-names>D.A.</given-names></name></person-group><article-title>Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts</article-title><source>Plants</source><year>2017</year><volume>6</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.3390/plants6040042</pub-id><?supplied-pmid 28937585?><pub-id pub-id-type="pmid">28937585</pub-id></element-citation></ref><ref id="B205-antibiotics-09-00480"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popova</surname><given-names>I.E.</given-names></name><name><surname>Hall</surname><given-names>C.</given-names></name><name><surname>Kubatova</surname><given-names>A.</given-names></name></person-group><article-title>Determination of lignans in flaxseed using liquid chromatography with time-of-flight mass spectrometry</article-title><source>J. Chromatogr. A</source><year>2009</year><volume>1216</volume><fpage>217</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2008.11.063</pub-id><?supplied-pmid 19070866?><pub-id pub-id-type="pmid">19070866</pub-id></element-citation></ref><ref id="B206-antibiotics-09-00480"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>M.R.L.</given-names></name><name><surname>Butler</surname><given-names>M.S.</given-names></name><name><surname>Phetsang</surname><given-names>W.</given-names></name><name><surname>Cooper</surname><given-names>M.A.</given-names></name><name><surname>Blaskovich</surname><given-names>M.A.T.</given-names></name></person-group><article-title>Fluorescent antibiotics: New research tools to fight antibiotic resistance</article-title><source>Trends Biotechnol.</source><year>2018</year><volume>36</volume><fpage>523</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2018.01.004</pub-id><?supplied-pmid 29478675?><pub-id pub-id-type="pmid">29478675</pub-id></element-citation></ref><ref id="B207-antibiotics-09-00480"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Chimenti</surname><given-names>P.</given-names></name><name><surname>Fazzari</surname><given-names>M.</given-names></name><name><surname>Granese</surname><given-names>A.</given-names></name><name><surname>Angiolella</surname><given-names>L.</given-names></name></person-group><article-title>Antimicrobial activity, synergism and inhibition of germ tube formation by crocus sativus-derived compounds against <italic>Candida</italic> spp.</article-title><source>J. Enzym. Inhib. Med. Chem.</source><year>2016</year><volume>31</volume><fpage>189</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1080/14756366.2016.1180596</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-09-00480-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Bioassays for testing Phytochemicals&#x02014;Uses and concerns.</p></caption><graphic xlink:href="antibiotics-09-00480-g001"/></fig><fig id="antibiotics-09-00480-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Phytochemicals as antimicrobials&#x02014;mode of action and their effectiveness against microbes.</p></caption><graphic xlink:href="antibiotics-09-00480-g002"/></fig><table-wrap id="antibiotics-09-00480-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00480-t001_Table 1</object-id><label>Table 1</label><caption><p>Plant-derived substances and their action against different microbes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Derivatives</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial sp.</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">* MIC Value</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Anogeissusa cuminata</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">terpenoids, flavonoids, saponins, tannins, alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.51 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.51 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Azadirachta indica</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x003b2;-sitosterol, flavonoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]<break/>[<xref rid="B84-antibiotics-09-00480" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
<break/>
<italic>H. pylori</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL<break/>128 &#x000b5;g/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Bauhinia variegata</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">terpenoids, flavonoids, tannins, saponins, glucoside,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Boerhaavia diffusa</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x003b2;-sitosterol, flavonoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Punica granatum</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">flavonoids, ellagitannin, punicalagin, ellagic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.67 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Soymida febrifuga</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">methyl angolensate, luteolin 7-O-glucoside, flavonoid, sitosterol, myricetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">067 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.51 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Terminalia chebula</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">flavonoids and flavins, terpenoids, steroids, alkaloids, tannins and their derivatives, glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.51 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Tinospora cordifolia</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">alkaloids terpenoids, lactones, glycosides, steroids, phenolics</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Tribulus terrestris</italic>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">flavonoids, flavonol glycosides, steroidal saponins and alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-antibiotics-09-00480" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. oxytoca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.27 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>K. pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.63 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.41 mg/mL</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Petroselinum crispum EO (Essential oil)</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">phenolic, flavonoids, coumarins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. cereus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.68 &#x000b5;L/mL</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B85-antibiotics-09-00480" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.80 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.62 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.80 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. typhimurium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.62 &#x000b5;L/mL</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Levisticum officinale EO</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">terpenoids, n-butylidene phthalide n-butyl-phthalide, sedanonic anhydride, d-terpineol, l, l phenolic,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. cereus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.62 &#x000b5;L/mL</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B85-antibiotics-09-00480" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.68 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.80 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. typhimurium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.62 &#x000b5;L/mL</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Occimomum basilicum EO</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">rosmarinic acid, phenol and terpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. cereus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.80 &#x000b5;L/mL</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B85-antibiotics-09-00480" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.68 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.80 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. typhimurium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.68 &#x000b5;L/mL</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Thymus vulgare EO</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-cymene, &#x003b3;-terpinene, thymol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>B. cereus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56 &#x000b5;L/mL</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B85-antibiotics-09-00480" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.27 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. typhimurium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56 &#x000b5;L/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cannabis sativa</italic> L., <italic>EO</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>phenol</italic>, <italic>flavonoid</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-antibiotics-09-00480" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Acrosta phylosuvaursi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ellagic and gallic acid tannins, flavonoids, phenol</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 &#x000b5;g/mL</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B87-antibiotics-09-00480" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Coptis chinensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">isoquinoline, alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">121 &#x000b5;g/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eucalyptus globulus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,8-cineole, &#x003b1;-pinene, p-cymene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">118 &#x000b5;g/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Larreatri dentata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alkaloids, lignans, flavonoid, terpenoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 &#x000b5;g/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Alpinia galanga</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-pinene, myrcene, limonene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mycobacterium smegmatis</italic><break/>mc2 155</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.12&#x02013;25 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-antibiotics-09-00480" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ammannia</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">dioxyflavanol, quercetin and kaempferol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125 &#x000b5;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-antibiotics-09-00480" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Berberis vulgaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">isoquinoline, alkaloids,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250&#x02013;1000 &#x000b5;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-antibiotics-09-00480" ref-type="bibr">90</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic>Acer saccharum</italic>
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">flavonoids, tannins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5 and 10 mg/mL</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B91-antibiotics-09-00480" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. mirabilis</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Catharanthus roseus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">limonene, terpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 mg/L </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-antibiotics-09-00480" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Holarrhena antidysenterica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">triterpenoids, sitosterol, phytosterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-antibiotics-09-00480" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cuminum cyminum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alkaloid, phenols, flavonoid, glycoside, saponin, tannin and steroid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-antibiotics-09-00480" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Salvia fruticosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">flavonoids, phenolics and rosemarinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. epidermidis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#x000b5;l/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-antibiotics-09-00480" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chenopodium Ambrosioides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-terpinene, ascaridole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">170.6 &#x000b5;l/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-antibiotics-09-00480" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Terminalia chebola</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ellagic acid, gallic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.1&#x02013;97.5 &#x000b5;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-antibiotics-09-00480" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Persea lingue</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">flavonoids,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.56 mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-antibiotics-09-00480" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ipomoea muricata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ipomine, ipalbine, ipalbidine and ipalbinium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 &#x000b5;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-antibiotics-09-00480" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hypericum olympicum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">essential oils, &#x003b1;-pinene, &#x003b2;-ocimene, &#x003b2;-caryophyllene, germacrene-D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-antibiotics-09-00480" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Alkanna orientalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-eudesmol, &#x003b1;-eudesmol and &#x003b3;-eudesmol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-antibiotics-09-00480" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eucalyptus tereticornis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">saponins, tannins, steroids flavonoids, cardiac glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 and 50 &#x000b5;g/mL<break/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-antibiotics-09-00480" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Salvia officinalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">phenols, terpenoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>E. cloacae</italic>,<break/><italic>E. coli</italic>,<break/><italic>S. typhimurium</italic>,<break/><italic>P. aeruginosa</italic>,<break/><italic>B. cereus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 mg/mL,<break/>0.045 mg/mL,<break/>0.045 mg/mL,<break/>0.045 mg/mL,<break/>0.09 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-antibiotics-09-00480" ref-type="bibr">102</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>* MIC corresponds to effect observed for the plant extract against given bacterial isolates.</p></fn></table-wrap-foot></table-wrap><table-wrap id="antibiotics-09-00480-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00480-t002_Table 2</object-id><label>Table 2</label><caption><p>Mechanism of action of plant-derived substances (PDSs) against broad range of microbes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemicals</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial Resistant Microbes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Flavonoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vaccinium macrocarpon</italic> Alt (cranberry)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modifies biofilm formation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Enterococcus faecalis</italic>, <italic>E. coli</italic>, <italic>Pseudomonas aeruginosa</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-antibiotics-09-00480" ref-type="bibr">114</xref>,<xref rid="B115-antibiotics-09-00480" ref-type="bibr">115</xref>,<xref rid="B116-antibiotics-09-00480" ref-type="bibr">116</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myricetin,<break/>robinetin,<break/>epigallocatechin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocks bacterial DNA synthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B117-antibiotics-09-00480" ref-type="bibr">117</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibit ATPase activity, GrYB protein, elevates extracellular phosphatase and &#x003b2;-galactosidase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>E. coli</italic>, <italic>S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-antibiotics-09-00480" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant-derived peptides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Moringa oleifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Membrane disruption</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>E. coli</italic>, <italic>S. aureus</italic>, <italic>P. aeruginosa</italic>,<break/><italic>S. Typhimurium</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-antibiotics-09-00480" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oils (EOs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Petroselinum crispum</italic> EO,<break/><italic>Levisticum officinale</italic> EO,<break/><italic>Ocimum basilicum</italic> EO, <italic>Thymus vulgaris</italic> EO<break/><italic>Cannabis sativa</italic> L., EO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase cell permeability, leakage of cell constituents, alteration of bacterial cell wall and membrane disturbance, ATP loss, inhibit protein synthesis, lead to pH disturbance, intracytoplasmic damage, DNA damage, inhibit quorum sensing<break/>Inhibits biofilm formation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bacillus cereus</italic>, <italic>Staphylococcus aureus</italic>, <italic>P. aeruginosa</italic>, <italic>E. coli</italic>,<break/><italic>S. Typhimurium</italic><break/><italic>S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-antibiotics-09-00480" ref-type="bibr">120</xref>,<xref rid="B121-antibiotics-09-00480" ref-type="bibr">121</xref>]<break/>[<xref rid="B102-antibiotics-09-00480" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tea tree oil (TTO)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">terpenes,<break/>monoterpenes,<break/>sesquiterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">disrupts membrane permeability, damages cell membrane, obstructs cell growth, cause cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>E. coli</italic>, <italic>S. aureus</italic>,<break/><italic>C. albicans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-antibiotics-09-00480" ref-type="bibr">122</xref>,<xref rid="B123-antibiotics-09-00480" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Natural Efflux pump inhibitors (EPIs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">reserpine, gallotannin,<break/>piperine, curcumin, berberine, chalcones, carnosic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibit various efflux pump in bacteria (EtBr EP, MexAB-OprM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR Uropathogenic <italic>E. coli</italic>, MDR, <italic>P. aeruginosa</italic> (clinical isolates)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-antibiotics-09-00480" ref-type="bibr">82</xref>,<xref rid="B90-antibiotics-09-00480" ref-type="bibr">90</xref>,<xref rid="B97-antibiotics-09-00480" ref-type="bibr">97</xref>,<xref rid="B121-antibiotics-09-00480" ref-type="bibr">121</xref>,<xref rid="B124-antibiotics-09-00480" ref-type="bibr">124</xref>,<xref rid="B125-antibiotics-09-00480" ref-type="bibr">125</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>